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9ABSTRACT
Chronic pain has been strongly associated with such symptoms as anxiety, 
depression, and anger, which are known to complicate pain treatment and outcome. 
In	acute	pain,	emotional	reactions,	e.g.	fear	and	avoidance,	function	as	a	beneficial	
warning signal. In chronic pain, the emotional components lose their usefulness 
and tend to maintain the disability.  Despite the co-occurrence of chronic pain 
symptoms, possible causality and linking mechanisms remain unclear.  In addition, 
due to the overlap between chronic pain symptoms and psychiatric symptoms, the 
psychiatric assessment is demanding.  
The aim of this cross-sectional study was to assess the prevalence of depression 
and anxiety in chronic pain, to examine the associations between chronic pain and 
depression, anxiety, and anger, and to assess possible mechanisms explaining these 
associations. 
Study participants comprised 100 consecutive chronic pain patients referred 
to the Meilahti Pain Clinic of Helsinki University Hospital. The study utilized both 
the psychiatric diagnostic approach (SCID-I interview for DSM-IV) and several 
self-administered questionnaires, i.e. Beck Depression Inventory  (BDI) , Pain 
Anxiety Symptom Scale-20 (PASS-20),  State Trait Anger Expression Inventory-2 
(STAXI-2),  and Harm Avoidance scale of Temperament and Character Inventory 
(TCI).	Concerning	the	BDI,	a	two-factor	model	with	specific	somatic	and	cognitive-
emotional subscales was utilized.  Current pain intensity was measured with Visual 
Analog Scale (VAS). 
The majority (75%) of the patients had at least one lifetime Axis I DSM-IV 
disorder. The most common disorders were mood and anxiety disorders. The 
prevalence	of	major	depressive	disorder	(MDD)	was	37%	and	of	a	specific	anxiety	
disorder	25%	over	the	past	12	months.	All	of	the	specific	anxiety	disorder	categories	
of DSM-IV were represented among the patients. The majority (77%) of the 
lifetime anxiety disorders preceded the onset of pain. The temporal relationship 
concerning mood disorders was different, as only 37% preceded pain onset. The 
Harm Avoidance dimension of the TCI was associated with pain-related anxiety 
(PASS-20).			The	experienced	pain	intensity	influenced	the	strength	of	the	association	
between the Harm Avoidance HA4 subscale and PASS-20. The association was 
stronger in patients who experienced a higher pain level than in those with a low 
level of pain.  A similar pain intensity-dependent effect was detected concerning 
the association between inhibited anger and the somatic symptoms of depression. 
Patients	who	fulfilled	the	diagnostic	criteria	of	MDD	scored	higher	 in	both	the	
somatic and cognitive-emotional subscales of the BDI compared with those without 
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MDD. However, the somatic-physical-related items were more strongly associated 
with the diagnosis of MDD. 
The prevalence of psychiatric disorders was high in chronic pain patients.  Due 
to the unclear boundaries between pain and psychiatric disorders, the assessment 
can be demanding.  Interpreting strictly the somatic criteria in the psychiatric 
diagnostic assessment reduces the sensitivity and may result in treatment failures 
due to missed diagnoses. 
The mechanisms linking chronic pain to depression and anxiety are complex. 
Analyzing the temporal relationship between the constructs can shed some light 
on the causality directions. Anger and aggression are seldom routinely assessed in 
pain patients.  Inhibited anger is easily overlooked in clinical practice and would 
require	more	active	screening.	In	addition,	personality	factors	may	influence	how	
patients	adjust	to	chronic	pain.	Understanding	the	personality	profile	is	useful	in	
more	individualized	and	efficient	treatment	planning.
In conclusion, the psychiatric diagnostic approach provides clinically important 
information on chronic pain patients. Assessing psychiatric comorbidity enables 
efficient	and	individualized	treatment	planning	in	chronic	pain.
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TIIVISTELMÄ
Psyykkiset liitännäisoireet ovat yleisiä kroonisessa kivussa, ja ne voivat vaikuttaa 
laaja-alaisesti kivun kokemiseen. Akuuttiin kipuun liittyvä välttämiskäyttäytyminen 
voi toimia suojaavana tekijänä edesauttaen paranemista. Sen sijaan kroonisessa 
kivussa nämä pelko ja välttämisreaktiot toimivat usein päinvastoin ylläpitäen kipuun 
liittyvää toiminnanvajausta.  Krooniseen kipuun yleisesti liittyviä oireita ovat ahdis-
tuneisuus, masentuneisuus, sekä aggression ja suuttumuksen tunteet. Psyykkisten 
liitännäisoireiden on todettu vaikeuttavan potilaiden hoitoa ja huonontavan hoidon 
ennustetta.  Kroonisen kivun ja psyykkisten liitännäisoireiden välillä vaikuttavat 
mekanismit ovat huonosti tunnettuja.  Lisäksi arviointia vaikeuttaa psyykkisten 
oireiden päällekkäisyys kipuoireiston kanssa. 
Tutkimuksessa pyrittiin selvittämään masentuneisuuden, ahdistuneisuuden 
sekä vihantunteiden esiintymistä kroonisilla kipupotilailla. Lisäksi tutkimuksessa 
arvioitiin miten koettu kivun voimakkuus heijastuu psyykkisiin oireisiin sekä nii-
den välisiin suhteisiin. 
Tutkimukseen osallistui 100 kroonista kipupotilasta Meilahden Kipuklinikal-
la. Menetelminä käytettiin DSM-IV luokitukseen perustuvaa diagnostista SCID-I 
haastattelua sekä Beckin Depressioasteikkoa (BDI), ahdistuneisuutta mittaavaa 
Pain Anxiety Symptom Scale-20 (PASS-20) -asteikkoa, suuttumuksen ilmaisua 
mittaavaa State Trait Anger Expression Inventory-2 (STAXI-2) -asteikkoa sekä 
Cloningerin Temperamenttimalliin liittyvää Harm Avoidance (vaikeuksien välttä-
minen) -asteikkoa.  Kivun voimakkuutta arvioitiin Visual Analog Scale (VAS) -mit-
tarilla.  Beckin depressioasteikosta muodostettiin kahden faktorin malli, joka sisälsi 
erilliset asteikot masennuksen kognitiivis-emotionaalisille ja somaattisille oireille. 
Suurimmalla osalla (75 %) potilaista oli jokin elinaikainen mielenterveyden häi-
riö. Yleisimpiä olivat mieliala- ja ahdistuneisuushäiriöt. Kuluneen 12 kuukauden 
aikana vakavaa masennuksen esiintyi 37 %:lla ja ahdistuneisuushäiriöitä 25 %:lla 
potilaista.  Verrattaessa elinaikaisten mieliala- ja ahdistuneisuushäiriöiden alka-
mista suhteessa kivun alkamiseen, 77 % ahdistuneisuushäiriöistä oli alkanut ennen 
kipua, kun taas masennuksen osalta tilanne oli erilainen, 37 % mielialahäiriöistä 
edelsi kipua. Temperamenttipiirre Harm Avoidance korreloi positiivisesti kipuun 
liittyvän ahdistuneisuusoireen kanssa. Potilailla, joilla kipu oli voimakkaampaa, 
myös Harm Avoidance yhdistyi voimakkaammin ahdistuneisuuden tasoon, ver-
rattuna niihin, joilla kipu oli lievempää. Vastaava kivun voimakkuudesta riippuva 
yhteys esiintyi myös vihan tunteen tukahduttamistaipumuksen (Anger-In) sekä 
depression somaattisten oireiden välillä.  Kun verrattiin Beckin depressionasteikon 
faktorimallin mukaisia asteikkoja vakavasti masentuneiden ja ei-masentuneiden 
12
kipupotilaiden välillä, sekä kognitiivis-emotionaaliset että somaattiset oirepisteet 
olivat korkeammat vakavasti masentuneilla. Kuitenkin somaattisten oireiden yh-
teys masennusdiagnoosiin oli selvempi kuin kognitiivis-emotionaalisten oireiden.
Kroonisilla kipupotilailla esiintyy runsaasti mielenterveyden häiriöitä, jotka tulee 
ottaa huomioon hoidossa.   Arviointia vaikeuttavat kroonisen kivun ja psyykkisten 
oireiden päällekkäisyys. Psyykkisiin häiriöihin, kuten masennukseen liittyy usein 
fyysisiä oireita, jotka tulee huomioida diagnostiikassa.  Mikäli diagnostisia kritee-
reitä tiukennetaan liikaa, osa potilaista jää vailla tarvitsemaansa hoitoa.  Kroonisen 
kivun, masennuksen ja ahdistuneisuuden yhteydet ovat monimuotoisia.  Oireistojen 
ajallisten suhteiden selventäminen voi tuoda lisävalaistusta syy- ja seuraussuhteiden 
arvioinnissa.  Krooniseen kipuun liittyvät vihantunteet voivat jäädä havaitsematta 
erityisesti mikäli ne suuntautuvat sisäänpäin. Myös persoonatekijät voivat osaltaan 
vaikuttaa siihen miten potilaat sopeutuvat krooniseen kipuun ja siihen miten hoitoa 
tulisi yksilöllisesti suunnitella.
Psykiatrisen diagnostiikan hyödyntäminen on tärkeä osa kipupotilaiden arvioin-
tia.  Psykiatrisella arvioinnilla saadaan kattava kokonaiskuva potilaan psyykkisistä 
oheisoireista sekä niiden kliinisestä merkityksestä ajatellen kroonisen kipupotilaan 
yksilöllistä ja kokonaisvaltaista hoitoa.
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1. Introduction
1. INTRODUCTION
The biopsychosocial model of chronic pain (Turk et al., 2002) has been one of the 
key approaches in pain medicine during the past decades. According to the model, 
pain is more than a perception or a simple sensory process. The biopsychosocial 
model of pain emphasizes that the psychological and social factors interact with the 
biological and physiological factors, modulating the pain experience and disability. 
The	biopsychosocial	model	reflects	the	idea	of	the	integration	of	mind	and	body,	
as opposed to pain being purely physical or psychological. 
According to the International Association for the Study of Pain (IASP), pain is 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (Merskey et al., 1994). The 
definition	emphasizes	the	role	of	emotion	in	pain.	The	affective	components	of	pain	
have a predominantly negative valence. Depression, anxiety, and fear have been the 
most often described emotions in chronic pain patients. Emotions are part of the 
pain experience, being more than just a consequence or reaction to it. Acute pain 
causes avoidance and behavioral reactions that protect the body from harm and 
further injuries. Unlike acute pain, chronic pain has no protective or other useful 
functions. Instead, chronic pain is strongly associated with emotional burden and 
physical incapacity. 
 The pain experience is formed by a multitude of interacting factors. The 
complexity is further increased by variability between individuals. As pain becomes 
more chronic, the psychological and social factors play an even bigger role in the 
maintenance of dysfunction and suffering (Gatchel, 2004). The factors behind the 
transition process from acute to chronic pain are not well understood. Mechanisms 
related to the alteration and sensitization of the peripheral and central nervous 
system have been among the central targets in pain research.  Psychosocial factors 
have emerged as an important factor in these processes. Considering the complexity 
of these factors, it is understandable that clear boundaries between chronic pain and 
emotions	are	difficult	to	define.		Previous	studies	have	revealed	a	close	association	
between pain and depression, however, the mechanisms underlying the association 
remain largely unclear. Anxiety as a symptom has been suggested to contribute to 
the	chronification	of	pain.	Far	less	is	known	about	anxiety	disorders	and	anger	in	
chronic pain patients.  
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2. REVIEW OF THE LITERATURE
2.1. CHRONIC PAIN
2.1.1. DEFINITIONS OF CHRONIC PAIN
Chronic	pain	is	defined	in	various	ways.	The	core	of	the	definition	is	that	the	pain	
lasts longer than expected based on the tissue healing process (Turk et al., 2010). 
Because	of	difficulties	 in	defining	the	 length	of	 the	normal	healing	process,	 the	
definition	of	chronic	pain	relies	on	time	markers	from	the	onset	of	pain.	The	time	
frame for chronicity may vary, typically being three or six months (Turk et al., 
2010). Regarding chronic pain, factors other than the original tissue pathology are 
thought to explain the presence and maintenance of pain.  Chronic pain results from 
sensitization of the neural system after input from tissue damage has diminished 
(Bonica, 1990).
The frequency of chronic pain may also vary. It can be continuous or episodic. 
Chronic	pain	can	be	classified	according	to	site	of	pain,	such	as	head,	lower	back,	
abdomen, etc., or organ system, such as gastrointestinal pain. Chronic pain is often 
classified	also	according	to	the	pathophysiological	mechanism.	Neuropathic	pain	is	
derived and maintained by pathological changes in the nervous system.  Nociceptive 
pain is associated with tissue damage, representing a normal reaction to mechanical 
or thermal stimuli.  Visceral pain refers to pain in inner organs.  Idiopathic pain 
refers to pain with unknown or poorly understood etiology.  Idiopathic pain includes 
disorders	such	as	temporomandibular	joint	disorder,	fibromyalgia,	irritable	bowel	
syndrome, interstitial cystitis, and pelvic pain (Merskey et al., 1994).  The underlying 
mechanisms of idiopathic pain are poorly understood, but they are supposed to be 
related to complex interactions of several factors, including genetic vulnerabilities 
and environmental factors (Diatchenko et al., 2006b).  The term psychogenic pain 
has been strongly rejected in the biopsychosocial approach to pain due to its dualistic 
view of psychological and medical factors (Sullivan 2000).
2.1.2. CHRONIC PAIN AND THE PSYCHIATRIC DIAGNOSTIC APPROACH
The psychiatric approach of assessing chronic pain is based on the psychiatric 
symptom criteria of a disorder according to the Diagnostic and Statistical Manual 
of Mental Disorders (DSM) (American Psychiatric Association, 2013) or the 
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International	Classification	of	Disease	(ICD)	(World	Health	Organization,	1994).	
The terms “pain” or “chronic pain”, are mentioned only occasionally in these 
classifications.	The	psychiatric	approach	to	chronic	pain	relies	much	on	the	diagnosis	
of Pain Disorder, the diagnostic criteria of which have changed in the most recent 
version of the DSM, the DSM-5 (American Psychiatric Association, 2013).  The 
former editions, the DSM-IV and the text revision DSM-IV-TR, as well as ICD-10, 
defined	Pain	Disorder	as	a	part	of	the	somatoform	disorders.	The	main	criteria	of	
Pain Disorder include duration of pain at least 6 months, pain without clear organic 
pathology, and distress because of pain.  Pain also interferes with important areas 
of functioning. Psychological factors are supposed to have an important role in the 
onset, severity, and maintenance of pain, however, medical background factors can 
also exist (American Psychiatric Association, 1994). In the recent DSM-5 (American 
Psychiatric Association, 2013), the criterion concerning the psychological etiology of 
the unexplained somatic symptoms has been abolished. The new category Somatic 
Symptom Disorder emphasizes the excessive distress, disability, and anxiety related 
to pain.  Pain Disorder is combined with other former somatoform disorders without 
a	separate	classification	(American	Psychiatric	Association,	2013).	
Despite the strong clinical impression about the linkage between pain and 
depression or anxiety, pain is not among the diagnostic criteria of any of the 
depression or anxiety disorders in the DSM.  However, the description part of the 
DSM related to the diagnostic manual states that pain and aches can be present in 
depression (American Psychiatric Association, 1994).   
2.1.3. PREVALENCE AND OUTCOME OF CHRONIC PAIN
Chronic pain is common in the general population. In a large cross-sectional study 
conducted in 15 European countries in 2004, 19% of the respondents had chronic 
pain, the prevalence ranging from 12% to 30%.  In Finland, the prevalence was 19% 
in	adult	subjects.	In	that	study,	chronic	pain	was	defined	as	having	a	duration	of	at	
least 6 months, being present during the last month at least twice a week, and having 
an intensity of 5 or higher on a 10-point scale  (Breivik et al., 2006). In another 
study in Finland with 6500 individuals, the prevalence of daily chronic pain was 
14.3% and that of any chronic pain 35.1% (Mantyselka et al., 2003).  Chronic pain is 
associated with other chronic conditions.  Among American adults with chronic back 
pain,	the	significantly	associated	other	physical	diseases	included	stroke,	high	blood	
pressure, asthma, digestive disease,  HIV, epilepsy, and impaired vision. The odds 
ratio for having any comorbid chronic physical disorder was 2.0 (95% CI 1.7-2.4) 
(Von Korff et al., 2005). A general view has been that females present more chronic 
pain than males (Rustoen et al., 2004, Wijnhoven et al., 2006, Tsang et al., 2008). 
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A potential explanation is that females more easily report pain than males or that 
females are more vulnerable to pain (Wijnhoven et al., 2006).  Another common 
reporting has been the increase in prevalence with age (Tsang et al., 2008). Having 
chronic pain has also been associated with low education and a low socioeconomic 
status (Eriksen et al., 2003, Rustoen et al., 2004, Saastamoinen et al., 2005). The 
discrepant	findings	of	epidemiological	studies	may	arise	from	differences	 in	the	
definitions	of	chronic	pain	related	to	duration,	frequency,	and	intensity.	Commonly	
utilized assessment methods include telephone interviews, postal surveys, and 
personal interviews (Verhaak et al., 1998).  
Chronic pain is a long-lasting disorder. In a European population study, 60% 
of subjects had had chronic pain for 2-15 years. The duration of pain in 21% of 
subjects exceeded 20 years (Breivik et al., 2006). In a 7-year population-based 
follow-up study conducted as a postal survey, one-third of patients originally with 
pain still had pain after 7 years.  Chronic pain was as prevalent at the beginning as 
at the end of the study (11% vs. 10%) (Papageorgiou et al., 2002). Among 973 acute 
non-radicular back pain patients in primary care, 41% had full recovery within 12 
months. Risk factors for non-recovery were higher initial pain intensity, previous 
sick leaves due to back pain, lower education, and emotional distress (Menezes Costa 
et al., 2009).  Several studies have emphasized the role of social support in chronic 
pain outcome.  Adequate social support and social relations have been associated 
with better pain adjustment and treatment outcome (Raichle et al., 2007, Miró et 
al., 2009, Jensen et al., 2011). On the other hand, excessive sympathy and worry 
of family members may have the opposite outcome, decreasing the adjustment to 
chronic pain (Boothby et al., 2004, Cano et al., 2004, Jensen et al., 2011).
Chronic pain is strongly connected to poor self-rated health appraisals and 
functional disability (Mantyselka et al., 2003).  In the Finnish population, the 
number of lost working days during the last 6 months was 19.8 days, which is 
among the highest in European countries (Breivik et al., 2006).  Population studies 
have revealed chronic pain to be a common, long-lasting, and debilitating disorder 
that causes marked functional disability. Chronic pain is considered to be one of the 
most costly medical conditions in society today (Maniadakis et al., 2000).
2.2. THE BIOPSYCHOSOCIAL MODEL OF CHRONIC PAIN
2.2.1. BACKGROUND OF THE BIOPSYCHOSOCIAL MODEL OF PAIN
The	gate	control	theory	of	pain	by	Melzack	and	Wall	was	one	of	the	first	pain	theories	
describing the connection between psychosocial factors and pain perception.  The 
theory maintained that pain is more than a simple sensory process. Instead, pain 
perception is based on a modulation by a complex feedback network comprising both 
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the peripheral and the central nervous systems (Melzack and Wall, 1965, Melzack, 
1993).   The model of Loeser presented the following four different domains in 
pain:  1) nociception, referring to the nerve function carrying information about 
tissue damage to the central nervous system, 2) pain, referring to the subjective 
experience, 3) suffering, referring to emotional negative responses to pain, and 4) 
pain behavior, referring to expressions of pain (Loeser, 2000).  
The	definition	of	pain	by	IASP	contains	the	emotional	factor	of	unpleasantness	
(Merskey et al., 1994).  Pain is aversive because of its original functioning as a 
warning signal.  The quality of the emotional components of pain is negative.   The 
general	finding	is	that	the	negative	emotional	components	in	one	way	or	another	
complicate pain management. The core of the biopsychosocial model of pain is that 
the psychological and social factors interact with the biological and physiological 
aspects of pain, modulating the pain experience and disability.  The model opposes 
the division of pain being purely either physiological or psychogenic.  As pain 
becomes more chronic, the psychological and social factors play an even bigger 
role in the maintenance of dysfunction and suffering (Gatchel, 2004)
The vulnerability-diathesis-stress model (Ingram et al., 2005) describes the 
action between the individual biologic and genetic factors (diathesis) and the 
environmental stress factors.  The result is formed by an interaction between 
the stress effect and the individual vulnerability.  A high level of vulnerability is 
associated with a lower tolerance for environmental stress factors, resulting in a 
predisposition for problems in mental health. Low vulnerability is protective against 
stress.  In addition to the genetic factors, vulnerability may involve factors such as 
personality, cognitions, and neurologic and medical conditions. Concerning mental 
health, the model was originally presented in relation to schizophrenia (Norman et 
al.,	1993).	Banks	and	Kerns	postulated	that	pain	has	a	specific	and	unique	character	
as a stressor related to its aversive and fear-evoking nature. The diathesis involves 
various personal and cognitive characteristics that exist before the onset of pain and 
are activated by pain, resulting in emotional disability (Banks and Kerns, 1996). 
While current psychological research strongly opposes the concept of a “pain-prone 
personality”, other theories have presented the role of personality as a possible 
vulnerability factor for chronic pain and pain-related disability (Ramirez-Maestre 
et al., 2004).  
Studies on depression and anxiety have dominated the biopsychosocial research 
on pain.  The majority of the studies have been psychological, where the term 
depression may refer to a symptom, mood, or disorder (Banks and Kerns, 1996). 
Anxiety-related studies have rarely used structured diagnostic methods.   Studies 
on personality and pain are few. In clinical practice, the biopsychosocial view of 
pain has become the most relevant and largely accepted approach also in “response 
to medicine’s inability to treat chronic, intractable pain and to control pain-related 
disability” (Duncan, 2000).
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2.2.2. BRAIN STRUCTURES IN CHRONIC PAIN
The term pain matrix refers to the brain areas associated with pain perception and 
processing. The pain matrix is not a distinct restricted unity, but shows remarkable 
variability between individuals and different pain conditions. The pain experience 
is	formed	by	an	interplay	of	several	brain	areas	rather	than	a	specific	pain	center.	
The areas active in pain are activated by other type of stimuli as well (Apkarian et 
al., 2011). Despite the association between pain and activity in certain brain areas, 
the	causality	of	the	findings	is	difficult	to	prove.				
 The spinothalamic tract is the main carrier of nociceptive information from the 
periphery to the central nervous system between the spinal cord and the thalamus. 
Connections to the brainstem area link nociception with the autonomic nervous 
system and homeostatic processes (Tracey and Mantyh, 2007).  The descending 
pain modulatory system (Fields, 2000), a structural neural network connecting the 
brainstem with the spinal cord, can either inhibit or facilitate pain transmission. 
The descending modulatory system is highly regulated by the biogenic amines 
serotonin and norepinephrine (Delgado, 2004). Several brain regions, such as the 
anterior cingulate cortex, insula, amygdala, and prefrontal cortex, have connections 
to the descending modulatory system. These connections could partly explain the 
interactions between anxiety, depression, and pain perception (Tracey and Mantyh, 
2007). The role of the descending pain modulatory system is further elucidated by 
the studies on placebo analgesia in humans. Anticipating pain relief has activated 
the descending inhibitory system, particularly the pathways connecting the frontal 
areas, the anterior cingular cortex (ACC), and the periaqueductal gray (PAG). The 
activation of the pain network induced by placebo resembles the activation seen 
in opioid analgesia (Petrovic et al., 2002).
One	of	 the	main	findings	of	 the	 recent	brain	 imaging	 studies	has	been	 the	
structural anatomical changes of the brain in chronic pain patients.   A well-described 
finding	has	been	the	reorganization	of	the	somatosensory	cortex	in	complex	regional	
pain syndrome (CRPS) (Maihöfner et al., 2003). Recent studies have shown the 
change in the distribution or loss of the gray matter in the areas associated with 
nociception, particularly in the prefrontal areas (Apkarian et al., 2004, Apkarian et 
al., 2011).  Reversibility of gray matter changes has been reported after successful 
pain treatment (Rodriguez-Raecke et al., 2009).
Recent	findings	have	suggested	that	the	active	brain	regions	in	chronic	pain	
differ from the regions in acute pain.  The brain activity in chronic pain shifts 
from the sensory areas to the emotional and motivational areas of the brain, 
including the medial prefrontal cortex, amygdala, and basal ganglia (Apkarian et 
al., 2011). The areas commonly involved in pain perception, such as the insula and 
the cingular cortex, are considered to be related to the emotional aspects of pain 
(Apkarian et al., 2011, Bushnell et al., 2013). A recent longitudinal study comparing 
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chronic pain patients with patients who had had pain, but had improved, reported 
functional changes in the connections between the nucleus accumbens and the 
reward-motivational	areas.	The	finding	was	linked	to	the	pain	chronification	process	
(Baliki et al., 2012). Recent theories have suggested that chronic pain is associated 
with functional changes concerning the pathways related to learning, memory, and 
reward in the prefrontal-mesolimbic areas (Mansour et al., 2014).
Figure 1.    Pain matrix of the brain. (PFC; Prefrontal cortex, ACC; Anterior cingulate cortex, HT; Hypothalamus, 
PAG; Periaqueductal gray, S1; Primary somatosensory cortex). Bolded ovals represent the areas related to 
the emotional pain network with connections to the descending pain modulatory system and PAG (Denk 
et al. 2014).
2.2.3. GENETIC FACTORS
Recent studies have indicated the importance of genetic factors in chronic pain. 
According to the results of twin studies, the heritability can range between 13% 
and 60% depending on the population and pain characteristics (Denk et al., 2014). 
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The variation of certain genes impacts both pain processing and the psychological 
vulnerability characteristics, e.g. personality traits (Diatchenko et al., 2006b).  The 
genes related particularly to the serotonergic and noradrenergic pathways have 
been investigated as possible mediators between pain and emotional processes. 
Among the most studied genes has been the catechol-O-methyltransferase (COMT) 
gene, which catabolizes catecholamines such as dopamine, norepinephrine, 
and epinephrine. The haplotypes of the gene have been related to the variation 
in pain sensitivity (Diatchenko et al., 2006a). In addition, pain sensitivity has 
been dependent on the interaction of the haplotype with the level of tendency to 
catastrophize in patients with shoulder pain. Patients with low COMT activity and 
high tendency to catastrophize had the highest pain ratings (George et al., 2008). 
Caspi and colleagues reported the moderating effect of the serotonin transporter 
gene polymorphism between stressful life events and depression (Caspi et al., 
2003).  Despite the fact that several other studies failed to replicate the results, 
the current opinion supports the view that the serotonin transporter polymorphism 
affects the relationship between stress and depression (Karg et al., 2011). A gender-
dependent mediating role of serotonin genes between pain and depression has been 
reported recently in patients after lumbar disc operation (Lebe et al., 2013).  The 
serotonin transporter gene polymorphism has been associated also with the risk of 
fibromyalgia	(Cohen	et	al.,	2002).	However,	in	the	most	recent	meta-analysis	no	
association was found between either the COMT polymorphism or the serotonin 
transporter	polymorphism	and	susceptibility	to	fibromyalgia	(Lee	et	al.,	2012).
2.3. PSYCHIATRIC COMORBIDITIES AND THE     
 BIOPSYCHOSOCIAL MODEL OF CHRONIC PAIN
2.3.1. ANXIETY IN CHRONIC PAIN
2.3.1.1. Anxiety symptoms and pain
Acute pain may trigger fear and anxiety.  The survival function of pain relies on the 
fear and avoidance it causes in order to protect individuals from further damage. 
Generally, fear can be understood as a behavioral and physiological reaction to 
immediate threat, while anxiety is related to the anticipation or expectancy of a 
potential threat.   Anxiety is characterized by cognitive and attentional biases for 
potential cues of danger or negative and threatening interpretations of neutral 
stimuli	(Bishop,	2007).			In	chronic	pain,	fear	and	anxiety	have	lost	their	beneficial	
function.  When fear and anxiety continue, they eventually become part of the 
psychopathology of chronic pain. 
In chronic pain literature, one of the most important models has been the Fear-
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Avoidance Model of Pain (Lethem et al., 1983, Vlaeyen et al., 2000).  According to 
this model, catastrophic interpretations of pain gradually lead to the avoidance of 
physical activity, which in turn is followed by degeneration of the muscular system, 
muscle coordination, and strength. This vicious cycle predisposes to exacerbation 
and maintenance of chronic pain (Leeuw et al., 2007).  
Similar to depression, anxiety has been associated with poorer pain treatment 
outcome and ability to return to work after rehabilitation (Burton, 1997, Dersh et 
al., 2007a).  Patients with high level of fear and anxiety report more severe pain and 
disability and have more exaggerated pain behavior (Vlaeyen et al., 1995, Crombez 
et al., 1999).  Reduction of anxiety level after multidisciplinary treatment is often 
accompanied by improvement in pain intensity, disability, and general activity. 
Pain-related anxiety has been presented to be one of the key factors for maintaining 
functional disability (McCracken and Gross, 1998). Pain-related fear may in fact 
be more disabling than the pain itself (Crombez et al., 1999). Having both anxiety 
and depression with chronic pain is associated with enhanced pain severity and 
disability compared with having only one of these disorders (Bair et al., 2008). 
2.3.1.2. Anxiety disorders in chronic pain patients
Anxiety disorders are common in the general population. In a Finnish population 
study, the prevalence of anxiety disorder was 4.1%, females having a higher 
prevalence (4.8%), mostly due to the higher prevalence of panic disorder in women 
(Pirkola et al., 2005). Anxiety disorders often go undiagnosed, untreated, or the 
treatment is not consistent with guideline recommendations (Sihvo et al., 2006).
Compared with depression, the prevalence of anxiety disorders has been less 
studied in chronic pain (Dersh et al., 2002).  In population studies, anxiety disorders 
have been as common in chronic pain patients as depression (McWilliams et al., 
2003, Von Korff et al., 2005). In a study across 17 countries, individuals with chronic 
back and neck pain were two to three times more likely than healthy persons to 
have panic disorder, social anxiety disorder, generalized anxiety disorder (GAD), 
or posttraumatic stress disorder (PTSD) during the past 12 months (Demyttenaere 
et al., 2007).
In clinical pain subjects, the rates of anxiety disorders have varied largely 
depending on the study population (Table 1). A prevalence as high as 60% has been 
recorded	in	patients	with	fibromyalgia	(Arnold	et	al.,	2006)	and	headache	(Verri	et	
al., 1998).  Comorbidity with mood disorders is also common (Dersh et al., 2002). 
Concerning	 the	specific	anxiety	disorders	 in	chronic	pain,	 the	most	studied	
disorders have been panic disorder, GAD, and PTSD (Dersh et al., 2002). Particularly 
high prevalences (80%) of PTSD have been reported in selected patient groups, e.g. 
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combat veterans (Beckham et al., 1997) and torture survivors (Williams et al., 2010).
Asmundson and colleagues presented possible linking mechanisms to explain 
the co-occurrence of pain and anxiety. They may reciprocally induce and maintain 
each other through common mechanisms such as physiological arousal or avoidance. 
Common vulnerability factors, such as trait anxiety, may also explain the co-
occurrence	(Asmundson	and	Katz,	2009).	 	Anxiety-sensitivity	(AS),	defined	as	a	
trait-like fear of bodily sensations (Reiss, 1997), has been presented as one mediating 
mechanism between pain and anxiety.  Individuals with a high level of AS have a 
hypervigilant tendency to monitor bodily symptoms and react with elevated anxiety 
and fear, resulting in exaggerated pain experience (Esteve and Camacho, 2008). 
In the classical study of Gatchel and colleagues, the anxiety disorders were more 
common	in	the	early	phases	of	pain.	Their	conclusion	was	that	anxiety	reflects	acute	
pain, while chronic pain is more characterized by depression (Gatchel et al., 1996).
26
2. Review of the literature
Ta
bl
e 
1. 
 D
is
tr
ib
ut
io
ns
 o
f a
xi
s 
I p
sy
ch
ia
tr
ic
 d
ia
gn
os
es
 in
 c
hr
on
ic
 p
ai
n 
pa
tie
nt
s.
R
ef
er
en
ce
 
st
ud
y
Ye
ar
C
lin
ic
al
 
po
pu
la
tio
n
C
ou
nt
ry
D
ia
gn
os
tic
 
cr
ite
ria
 (
m
et
ho
d)
M
oo
d 
di
so
rd
er
A
nx
ie
ty
 d
is
or
de
r
O
th
er
 d
is
or
de
r
R
ei
ch
 e
t 
al
.
19
83
43
 p
ai
n 
cl
in
ic
 
pa
tie
nt
s,
 1
5M
 
28
F
U
SA
D
SM
-I
II
(s
em
i-
st
ru
ct
ur
ed
 
in
te
rv
ie
w
)
C
ur
re
nt
M
D
D
 2
3%
 
D
ys
th
ym
ia
 7
%
 
C
ur
re
nt
A
nx
ie
ty
 d
is
or
de
r 
7%
C
ur
re
nt
A
dj
us
tm
en
t 
di
so
rd
er
 1
4%
Su
bs
ta
nc
e 
us
e 
di
so
rd
er
 2
8%
  
So
m
at
of
or
m
 d
is
or
de
r 
53
%
La
rg
e
19
86
50
 p
ai
n 
cl
in
ic
 
pa
tie
nt
s
N
ew
 
Ze
al
an
d
D
SM
-I
II
(s
em
i-
st
ru
ct
ur
ed
 
in
te
rv
ie
w
)
C
ur
re
nt
M
D
D
 8
%
  
D
ys
th
ym
ia
 2
8%
C
ur
re
nt
A
nx
ie
ty
 d
is
or
de
r 
8%
 
Pa
ni
c 
di
so
rd
er
 2
%
PT
SD
 2
%
G
A
D
 4
%
 
C
ur
re
nt
So
m
at
of
or
m
 d
is
or
de
r 
16
%
Fi
sh
ba
in
 
et
 a
l.
19
86
28
3 
pa
in
 c
lin
ic
 
pa
tie
nt
s,
 1
56
M
  
12
7F
U
SA
D
SM
-I
II 
(s
em
i-
st
ru
ct
ur
ed
 
in
te
rv
ie
w
)
C
ur
re
nt
M
D
D
 5
%
 
D
ys
th
ym
ia
 2
3%
  
M
D
D
+D
ys
th
ym
ia
 
28
%
 
C
ur
re
nt
A
ny
 a
nx
ie
ty
 d
is
or
de
r 
in
cl
ud
in
g 
ad
ju
st
m
en
t 
di
so
rd
er
 6
3%
 
G
A
D
 1
5%
C
ur
re
nt
A
dj
us
tm
en
t 
di
so
rd
er
 w
ith
 m
oo
d 
sy
m
pt
om
s 
28
%
C
on
ve
rs
io
n 
38
%
 
Su
bs
ta
nc
e 
de
pe
nd
en
ce
 1
5%
So
m
at
iz
at
io
n 
4%
C
on
ve
rs
io
n 
38
%
Ps
yc
ho
ge
ni
c 
pa
in
 0
.3
%
Po
la
tin
 
et
 a
l.
19
93
20
0
 p
at
ie
nt
s 
w
ith
 c
hr
on
ic
 
ba
ck
 p
ai
n
U
SA
D
SM
-I
II-
R
(S
C
ID
-I
)
C
ur
re
nt
 M
D
D
 4
5%
 
Li
fe
tim
e 
M
D
D
 6
4%
Li
fe
tim
e 
bi
po
la
r 
2%
Li
fe
tim
e 
dy
st
hy
m
ia
 
2%
Li
fe
tim
e
A
nx
ie
ty
 d
is
or
de
rs
 1
9%
Pa
ni
c 
di
so
rd
er
 3
%
Ph
ob
ic
 d
is
or
de
rs
 1
1%
O
C
D
 2
%
PT
SD
 1
%
G
A
D
 2
%
Li
fe
tim
e 
Su
bs
ta
nc
e 
ab
us
e 
di
so
rd
er
 3
6%
 
So
m
at
of
or
m
 d
is
or
de
r 
97
%
Ve
rr
i e
t 
al
.
19
98
88
 c
hr
on
ic
 
he
ad
ac
he
 
pa
tie
nt
s,
 1
8M
 
70
F
It
al
y
D
SM
-I
II-
R
(S
C
ID
-I
/P
)
C
ur
re
nt
 M
D
D
 2
5%
  
Li
fe
tim
e 
M
D
D
  
39
%
 
D
ys
th
ym
ia
 1
7%
 
C
ur
re
nt
Pa
ni
c 
di
so
rd
er
 5
%
 
So
ci
al
 p
ho
bi
a 
 1
3%
Si
m
pl
e 
ph
ob
ia
  
24
%
 
G
A
D
 7
0
%
C
ur
re
nt
So
m
at
of
or
m
 d
is
or
de
r 
6%
A
rn
ol
d 
et
 a
l.
20
0
6
78
 fi
br
om
ya
lg
ia
 
pa
tie
nt
s
U
SA
D
SM
-I
V
(S
C
ID
-I
/P
)
Li
fe
tim
e 
M
D
D
 6
2%
 
B
ip
ol
ar
 d
is
or
de
r 
13
%
 
D
ys
th
ym
ia
 1
%
Li
fe
tim
e
A
ny
 a
nx
ie
ty
 d
is
or
de
r 
60
%
 
Pa
ni
c 
di
so
rd
er
 2
8%
 
A
go
ra
ph
ob
ia
 1
%
So
ci
al
 p
ho
bi
a 
21
%
 
Sp
ec
ifi
c 
ph
ob
ia
 2
2%
 
O
C
D
 6
%
PT
SD
 2
3%
G
A
D
 5
%
 
Li
fe
tim
e
Su
bs
ta
nc
e 
us
e 
di
so
rd
er
 2
6%
Ea
tin
g 
di
so
rd
er
 9
%
So
m
at
of
or
m
 d
is
or
de
r 
1%
27
C
as
tr
o 
et
 
al
.
20
0
9
40
0
 p
ai
n 
cl
in
ic
 
pa
tie
nt
s,
 6
9M
 
33
1F
A
rg
en
tin
a
D
SM
-I
V
(M
IN
I)
C
ur
re
nt
 M
D
D
 4
2%
 
Pa
st
 M
D
D
 5
8%
 
D
ys
th
ym
ia
 5
4 
%
C
ur
re
nt
Pa
ni
c 
di
so
rd
er
 7
%
A
go
ra
ph
ob
ia
 9
%
So
ci
al
 p
ho
bi
a 
37
%
Sp
ec
ifi
c 
ph
ob
ia
 4
%
 
O
C
D
 3
%
PT
SD
 2
%
G
A
D
 5
%
H
yp
oc
ho
nd
ria
 1
1%
Su
bs
ta
nc
e 
us
e 
di
so
rd
er
 4
%
Ea
tin
g 
di
so
rd
er
 2
%
G
er
ha
rd
t 
et
 a
l.
20
11
11
0
 p
op
ul
at
io
n-
ba
se
d 
pa
tie
nt
s 
w
ith
 c
hr
on
ic
 
pa
in
, 4
7M
 6
3F
G
er
m
an
y
D
SM
-I
V
 (
SC
ID
-I
)
C
ur
re
nt
M
D
D
 7
%
M
oo
d 
di
so
rd
er
s 
13
%
 
D
ys
th
ym
ia
 3
%
 
C
ur
re
nt
A
nx
ie
ty
 d
is
or
de
r 
21
%
 
Pa
ni
c 
di
so
rd
er
 6
%
A
go
ra
ph
ob
ia
 4
%
 
So
ci
al
 p
ho
bi
a 
5%
 
Sp
ec
ifi
c 
ph
ob
ia
 6
%
C
ur
re
nt
A
dj
us
tm
en
t 
di
so
rd
er
 3
%
Su
bs
ta
nc
e 
us
e 
di
so
rd
er
 7
%
Ea
tin
g 
di
so
rd
er
 6
%
R
em
e 
et
 
al
.
20
11
56
5 
lo
w
 b
ac
k 
pa
in
 s
ic
k 
lis
t 
pa
tie
nt
s,
 2
73
M
  
27
9F
N
or
w
ay
D
SM
-I
V
(M
IN
I)
C
ur
re
nt
 M
D
D
 3
%
Pa
st
 M
D
D
 8
%
C
ur
re
nt
 d
ys
th
ym
ia
 
1% Pa
st
 m
an
ic
 e
pi
so
de
 
1%  
C
ur
re
nt
 a
nx
ie
ty
 d
is
or
de
r 
12
%
 
Li
fe
tim
e 
an
xi
et
y 
di
so
rd
er
 3
9%
 
C
ur
re
nt
 p
an
ic
 d
is
or
de
r 
1%
 
Li
fe
tim
e 
pa
ni
c 
di
so
rd
er
 5
%
C
ur
re
nt
 a
go
ra
ph
ob
ia
 4
%
Li
fe
tim
e 
ag
or
ap
ho
bi
a 
5%
C
ur
re
nt
 s
oc
ia
l p
ho
bi
a 
5%
C
ur
re
nt
 O
C
D
 1
%
C
ur
re
nt
 P
TS
D
 1
%
 
C
ur
re
nt
 G
A
D
 4
%
 
C
ur
re
nt
 a
nd
 p
as
t 
al
co
ho
l u
se
 
di
so
rd
er
 2
.2
%
 
C
ur
re
nt
 s
om
at
of
or
m
 d
is
or
de
r 
18
%
 
R
ad
at
 e
t 
al
.
20
13
18
2 
ne
ur
op
at
hi
c 
pa
in
 p
at
ie
nt
s,
 
87
M
 9
5F
, i
n 
ne
ur
ol
og
ic
 a
nd
 
pa
in
 u
ni
ts
Fr
an
ce
D
SM
-I
V
(M
IN
I)
C
ur
re
nt
 M
D
D
 1
7%
 
Li
fe
tim
e 
M
D
D
 4
0
%
 
C
ur
re
nt
 d
ys
th
ym
ia
 
1% C
ur
re
nt
 b
ip
ol
ar
 1
%
 
Li
fe
tim
e 
bi
po
la
r 
7%
C
ur
re
nt
 a
nx
ie
ty
 d
is
or
de
r 
20
%
 
Li
fe
tim
e 
an
xi
et
y 
di
so
rd
er
 3
9%
 
C
ur
re
nt
 p
an
ic
 d
is
or
de
r/
 
ag
or
ap
ho
bi
a 
14
%
 
Li
fe
tim
e 
pa
ni
c 
di
so
rd
er
/ 
ag
or
ap
ho
bi
a 
28
%
C
ur
re
nt
 s
oc
ia
l p
ho
bi
a 
2%
 L
ife
tim
e 
so
ci
al
 p
ho
bi
a 
6%
C
ur
re
nt
 O
C
D
 2
%
 
Li
fe
tim
e 
O
C
D
 2
%
C
ur
re
nt
 P
TS
D
 3
%
 
Li
fe
tim
e 
PT
SD
 7
%
 
C
ur
re
nt
 G
A
D
 1
2%
 
Li
fe
tim
e 
G
A
D
 2
3%
A
bb
re
vi
at
io
ns
: M
=M
al
e,
 F
=F
em
al
e,
 M
D
D
=M
aj
or
 D
ep
re
ss
iv
e 
D
is
or
de
r, 
O
C
D
=O
bs
es
si
ve
-C
om
pu
ls
iv
e 
D
is
or
de
r, 
G
A
D
=G
en
er
al
iz
ed
 A
nx
ie
ty
 D
is
or
de
r, 
PT
SD
=P
os
tt
ra
um
at
ic
 
St
re
ss
 D
is
or
de
r, 
D
SM
=D
ia
gn
os
tic
 a
nd
 S
ta
tis
tic
al
 M
an
ua
l o
f 
M
en
ta
l D
is
or
de
rs
, S
C
ID
-I
 =
St
ru
ct
ur
ed
 C
lin
ic
al
 In
te
rv
ie
w
 f
or
 D
SM
-I
V
 A
xi
s 
I D
is
or
de
rs
, S
C
ID
-I
/P
=S
tr
uc
tu
re
d 
C
lin
ic
al
 In
te
rv
ie
w
 f
or
 D
SM
-I
V
 A
xi
s 
I D
is
or
de
rs
 P
at
ie
nt
 E
di
tio
n,
 M
IN
I=
M
in
i I
nt
er
na
tio
na
l N
eu
ro
ps
yc
hi
at
ric
 In
te
rv
ie
w
 
28
2. Review of the literature
2.3.1.3. Trait anxiety and pain 
The inter-individual variation in the pain experience has evoked interest in examining 
whether	personality-related	factors	can	influence	the	pain	experience.		Based	on	
the psychoanalytic theories, Engel introduced the term “pain-prone personality”. 
According to his model, individuals with certain personality characteristics are more 
susceptible	 to	pain.	 	Chronic	pain	 is	suggested	to	be	a	reflection	of	unresolved	
inner psychological traumas converted into somatic symptoms.  Among affected 
individuals, chronic pain functions as a variant of or a substitute for depression, 
aggression, or guilty feelings (Engel, 1959).   Engel’s model has subsequently been 
criticized for lacking empirical evidence and for supporting the dualistic mind-body 
distinction (Sullivan et al., 2001). 
The Minnesota Multiphasic Personality Inventory (MMPI) (Butcher et al., 1989), 
a trait-dimensional personality inventory, has been commonly used in pain research. 
The MMPI was thought to be capable of distinguishing patients with organic pain 
from patients with psychogenic or functional pain (Hanvik, 1951).  According to 
MMPI studies, chronic pain patients were characterized by high scores on the 
hypochondriasis, hysteria, and depression subscales of the MMPI (Strassberg et 
al., 1981, Love et al., 1987). However, both earlier and recent studies have shown the 
state dependence of several MMPI scales.  MMPI scores have changed or improved 
after pain treatment (Hagedorn et al., 1985, Love et al., 1987, Fishbain et al., 2006). 
The	final	conclusion	has	been	that	the	studies	using	MMPI	could	not	indicate	any	
specific	personality	profile	for	chronic	pain	patients	(Prokop	et	al.,	1980,	Love	et	
al., 1987, Wade et al., 1992).
Neuroticism, included in most of the major personality trait models (Eysenck, 
1947, McCrae and Costa, 1987, Costa and McCrae, 1992, Zuckerman et al., 1993), 
is characterized by a tendency to experience negative emotions such as anxiety, 
worry, irritability, instability, and anger.  Neuroticism has been associated with 
enhanced somatic complaints and experience of bodily sensations (Watson et 
al., 1989).  It has been associated also with discrepancies between subjective and 
objective health perceptions (Costa and McCrae, 1987). Regarding pain, neuroticism 
has been associated with elevated reported pain intensity (Ramirez-Maestre et al., 
2004). In some studies, neuroticism has been associated with the perceived distress 
of pain, but not with the experienced pain level itself (Wade et al., 1992, Schmidt et 
al., 2011). A high level of neuroticism predicted ineffective strategies to solve pain-
related problems, which in turn were linked to greater pain intensity (Ramirez-
Maestre et al., 2004).   
Harm avoidance (HA), one of the temperament traits in the psychobiological 
personality model of Robert Cloninger, is characterized by a tendency to react 
intensively to aversive stimuli with fear, withdrawal, or behavioral inhibition. 
Temperament is related to the automatic emotional reactions to an experience 
and environmental events (Cloninger et al., 1993). Elevated levels of HA have been 
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robustly associated with anxiety and depression (Miettunen et al., 2012) and are 
likely to be both state- and trait-related (Abrams et al., 2004). Studies utilizing 
the Temperament and Character Inventory (TCI) (Cloninger et al., 1994) have 
reported an elevated level of HA in chronic pain patients compared with healthy 
controls	(Table	2).	The	second	most	constant	finding	has	been	low	self-directedness	
associated with chronic pain (Conrad et al., 2013).  An elevated score of HA has 
been measured particularly  in migraine (Di Piero et al., 2001, Mongini et al., 2005, 
Abbate-Daga et al., 2007, Sánchez-Román et al., 2007),  musculoskeletal  (Boz et 
al.,	2004,	Malmgren-Olsson	et	al.,	2006),	and	fibromyalgia	patients	(Mazza	et	al.,	
2009, Lundberg et al., 2009, Glazer et al., 2010).  As anxiety and depression are 
common in chronic pain, their state effect may partly explain the elevated level of HA 
(Mongini et al., 2005). In other studies, high HA has persisted despite controlling 
for the possible state effect of anxiety and depression (Anderberg et al., 1999, Mazza 
et al., 2009).
Table 2. Temperament and Character Inventory (TCI) findings in chronic pain patients.
Reference study Clinical population TCI scores in chronic pain 
patients
Abbate-Daga et al., 2007 Migraine (n=105); healthy 
controls (n=79)
HA↑, P↑, SD ↓
Anderberg et al., 1999 Fibromyalgia (n=38); controls 
(n=38 )
HA↑
Boz et al., 2004 Migraine patients (n=51); 
tension-type headache patients 
(n=81); healthy controls (n=82);
HA ↑ in tension-type headache 
patients
Boz et al., 2007 Tension headache  (n=45) 
healthy controls (n=50)
HA ↑, SD ↓
Conrad et al., 2007 Chronic pain mixed (n=207) 
healthy controls (n =105)
HA ↑, SD ↓, C ↓
Di Piero et al., 2001 Migraine patients (n=121)  
tension-type headache patients 
(n=42)
Both groups HA ↑, patients 
with migraine NS ↓, P ↑
Gencay-Can et al., 2012 Fibromyalgia (n=42 ); healthy 
controls (n=48)
HA ↑, ST ↑, SD ↓
Glazer 2010 Fibromyalgia  (n=129); first-
degree relatives (n=27); healthy 
controls (n=30)
HA ↑ in patients and  first-
degree relatives
Lundberg et al., 2009 Fibromyalgia (n=191); healthy 
controls (n=652)
HA ↑, P ↑, SD ↓
Lundqvist et al., 2005 Vestibulodynia  
(n=28 ); controls (n=28 ) 
HA ↑
Malmgren-Olsson et al., 2006 Musculoskeletal pain (n=78); 
healthy controls (n=118)
HA ↑, SD ↓
Mazza et al., 2009 Fibromyalgia (n=60); healthy 
controls (n=80)
HA ↑, SD ↓
Mongini et al., 2005 Migraine  (n=49); healthy 
controls (n=47)
HA ↑, P ↑, SD ↓
Sánchez-Román et al., 2007 Migraine (n=142); healthy 
controls (n=108+269);  non-
migraine pain patients (n=30)
Migraine patients HA ↑, non-
migraine pain patients HA ↑, 
NS ↓, SD ↓, C ↓
Harm Avoidance (HA); Self-Transcendence (ST); Self-Directedness (SD); Persistence (P); 
Novelty seeking (NS); Cooperativeness  (C)
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2.3.1.4. Assessing anxiety in chronic pain
Several instruments and approaches have been used in the assessment of anxiety 
in chronic pain. Anxiety as a symptom is multifaceted, having cognitive, emotional, 
and physiological characteristics. The questionnaires vary according to the extent to 
which they emphasize certain symptoms over others.  Scales such as the Hospital 
Anxiety and Depression Scale (HADS) (Zigmond et al., 1983) or the State-Trait 
Anxiety Inventory (STAI) (Spielberger et al., 1983) have been used in chronic 
pain studies.  These measures can be seen as general measures of anxiety, which 
is why their validity in pain-related anxiety or special patient groups has been 
criticized	(Julian,	2011).	Other	pain-specific	anxiety	scales	include	the	Pain	Anxiety	
Symptoms Scale (PASS) (McCracken et al., 1992), a 40-item self-report assessing 
cognitive anxiety, fearful appraisals, escape and avoidance of pain, and physiological 
symptoms, and its  shortened version, Pain Anxiety Symptom Scale-20 (PASS-
20) (McCracken and Dhingra, 2002). The Fear-Avoidance Beliefs Questionnaire 
(FABQ) (Waddell et al., 1993) emphasizes more how pain-related anxiety is linked 
to the restriction in work and physical activity and the avoidance of pain. The 
McGill Pain Questionnaire (MPQ) (Melzack, 1975) is a word list questionnaire with 
adjectives describing the pain sensation and experience.  Other fear-avoidance-
related measures are questionnaires such as the Tampa Scale for Kinesiophobia 
(TSK) (Kori et al., 1990), addressing fear in movement and pain catastrophizing, 
and the Fear of Pain Questionnaire (FPQ) (McNeil et al., 1998).
The symptom-overlapping phenomenon, similar to that seen in pain-depression 
assessment studies, may have an impact on pain-anxiety studies as well.  The anxiety 
score may rely strongly on the level of pain severity (McCracken et al., 1996).
In conclusion, anxiety and anxiety disorders are common in chronic pain and 
have been connected to enhanced disability in chronic pain patients. The fear-
avoidance model of chronic pain has been one of the major models presenting how 
the	pain	chronification	process	results	from	fear-related	avoidance	behavior.	The	
mechanisms underlying the co-occurrence between pain and anxiety are poorly 
understood. Personality-related factors may predispose pain patients to higher 
distress and ineffective coping. Several studies have shown the positive correlation 
between the temperament trait Harm Avoidance and chronic pain. However, due 
to the cross-sectional design of the studies, no causality can be assigned.
2.3.2. DEPRESSION IN CHRONIC PAIN
2.3.2.1. Prevalence of depression in chronic pain
Depression is the most widely reported and studied mental disorder in chronic pain. 
The prevalence of depression in chronic pain patients appears to be markedly higher 
than in the normal population (Dersh et al., 2002).   The prevalence of depression in 
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this patient group varies considerably depending on the study population, ranging 
between	1.5%	and	100%	(Bair	et	al.,	2003).	The	studies	vary	in	their	definition	and	
measurement of chronic pain and depression.  The word depression may refer 
to mood, symptom, or disorder (Banks and Kerns, 1996).  The majority of the 
psychology-based studies assess depression by self-report questionnaires instead 
of structured diagnostic interviews.  The heterogeneity of the studies causes major 
difficulties	when	comparing	results	(Dersh	et	al.,	2002).
In a population study covering 17 countries worldwide, the prevalence of major 
depression in patients with chronic back or neck pain varied between 2.5% and 
15.7%. The odds ratio against not having chronic pain was 2.3 for depression 
(Demyttenaere et al., 2007). The National Comorbidity Survey Replication study 
with 9282 adult Americans reported a 19% prevalence of chronic spinal pain during 
the past 12 months among the respondents. Of the individuals with chronic pain, 
12.6% had major depression, 4.4% bipolar I or II disorder, and 17.5% any mood 
disorder (Von Korff et al., 2005).  
The prevalence of depression can be very high in clinical patient populations 
and in pain clinic samples, up to 100% (Romano and Turner, 1985).  Studies based 
on DSM criteria generally report a prevalence of current MDD from 30% to 45%, 
while the lifetime prevalence may reach 60% (Table 1). 
2.3.2.2. Association between chronic pain and depression
Despite the high co-occurrence of chronic pain and depression, the causality of 
the association is unclear.  The causality, the “hen and egg dilemma”, has been 
one of the key questions in pain-depression studies. Depression severity has been 
positively related to pain severity, frequency of pain, and number of pain sites. 
Also the duration of pain has been associated with depression (Fishbain et al., 
1997).  Depression increased the perception of pain and lowered pain tolerance 
(Banks and Kerns, 1996).  In follow-up studies, depression has predicted onset of 
chronic pain, and also chronic pain at baseline has predicted onset of depression 
(Gureje et al., 2001, Chou, 2007, Meyer et al., 2007).  One may conclude that there 
is evidence for a reciprocal pattern.  Chronic pain may function as a risk factor for 
depression (Fishbain et al., 1997), but also the opposite direction, i.e. depression 
being a risk factor for pain, may exist (Chou, 2007, Meyer et al., 2007). In the review 
of Fishbain et al. (1997), the majority of the studies supported that depression 
temporally followed pain, instead of being antecedent to pain.  On the other hand, 
Polatin reported that 54% of pain patients with depression had experienced the 
symptoms before the onset of pain (Polatin et al., 1993).
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2.3.2.3. Assessing depression in chronic pain
Considering the high psychiatric comorbidities, one potential explanation offered 
has been the symptom overlap phenomenon. Chronic pain and psychiatric 
disorders, such as depression and anxiety, share a number of common symptoms. 
Insomnia,	fatigue,	restlessness,	and	difficulties	in	concentrating	and	thinking	can	be	
attributed directly to the effect of pain or they can be signs of a psychiatric disorder. 
According to the DSM-IV, the symptom criteria that are fully attributed to the 
somatic condition should not be included in the psychiatric diagnosis (Diagnostic 
and Statistical Manual of Mental Disorders, 4th edition, 1994). However, there is 
no general opinion concerning the assessment procedure of these items in the 
context of various medical conditions. The judgment concerning the etiology of a 
specific	symptom	is	demanding	and	leaves	room	for	interpretation	(Kathol	et	al.,	
1990, Koenig et al., 1997, Akechi et al., 2003, Wilhelm et al., 2004, Mitchell et al., 
2012). Thus, the high prevalence of psychiatric disorders in chronic pain can be an 
overestimation because of the overlapping of somatic symptoms. 
Wilson and colleagues (2001) used three different approaches for diagnosing 
depression in 129 chronic pain patients: the inclusive method (standard DSM-IV 
criteria for major depression), the etiologic method (excluding symptoms from 
the diagnosis if they could be attributed to pain), and the substitutive method 
(somatic symptom criteria of depression were replaced by cognitive-behavioral 
symptoms commonly related to depression).  The prevalences of depression were 
35.7% (inclusive), 30.3% (substitutive), and 19.4% (etiologic).   In addition, patients 
were asked about their opinion regarding the origin of their somatic depression 
symptoms.  Most of the patients linked the symptoms directly to pain, after which 
45% of the patients who originally met the inclusive criteria no longer met the criteria 
of depression. However, the group scored equally high in the Beck Depression 
Inventory compared with those with major depression.  The authors of the study 
cautioned clinicians against causality analysis of the symptoms in the diagnosis 
of depression in chronic pain (Wilson et al., 2001). The inclusive method has also 
shown better sensitivity and reliability compared with the other methods (Koenig 
et al., 1997). 
The most widely used assessment tool in pain-depression studies, the Beck 
Depression Inventory (BDI), was originally developed to assess the severity of 
depression in psychiatric patients and to follow their response to therapy (Beck 
et al., 1961). The BDI possesses similar kinds of problems concerning symptom 
overlap, and its ability to assess depression in medical illnesses has been questioned 
(Cavanaugh et al., 1983, Kathol et al., 1990, Wesley et al., 1991, Aikens et al., 1999, 
Forkmann et al., 2009). Similar concerns have been addressed regarding other 
scales, e.g. the Middlesex Hospital Questionnaire Depression scale (MHQ-D) (Love, 
1987) or the Hospital Anxiety and Depression Scale (HADS) (Zigmond et al., 1983).
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Some	authors	have	suggested	that	the	symptom	profile	of	depression	in	chronic	
pain differs from psychiatric depression.  Symptoms related to negative cognitions 
of self have been less common than somatic-behavioral symptoms of depression 
(Morley et al., 2002, Poole et al., 2006).  The somatic subscales of depression 
may be strongly correlated with pain intensity (Wesley et al., 1991). In their study, 
Morley and colleagues analyzed 1947 chronic pain patients using BDI.  The factor 
model	from	this	data	included	two	specific	factors,	the	Negative	View	of	Self	and	the	
Somatic and Physical Function factors. Several of the depression-related emotional 
items, such as sadness, pessimism, or suicidal ideas, were not included in the factor 
model. Their conclusion was that depression in chronic pain is different from the 
psychiatric model of depression, and that BDI is likely to measure general distress 
rather than depression in chronic pain (Morley et al., 2002). 
To sum up, depression has been the most studied psychiatric disorder in chronic 
pain. The prevalence of depression is generally high, however, large variability exists 
between studies. Depression has shown positive correlations with pain-related 
variables such as pain severity, duration of pain, or number of pain sites. Longitudinal 
studies suggest a reciprocal risk pattern, with individuals who have either pain or 
depression being at risk for developing the other. Diagnosing depression in chronic 
pain	entails	difficulties	due	to	the	symptom	overlap	phenomenon.	Understanding	
and formulating the construct of depression in chronic pain have been goals in 
psychological studies on chronic pain. 
2.3.3. ANGER IN CHRONIC PAIN
Feelings of anger have been reported to be common in chronic pain patients (Okifuji 
et al., 1999, Greenwood et al., 2003, Fishbain et al., 2011). In the psychoanalysis-
based theories of Engel (1959), chronic pain was a substitute for anger and 
depression,	particularly	in	patients	unable	to	express	their	emotions.	Definitions	
of	anger	vary	in	the	different	theories.	Most	commonly,	anger	is	defined	as	a	normal	
emotion with a variable range of intensity, from mild irritation to rage. It is a reaction 
to a perceived threat or injustice to oneself or persons near oneself (Smith, 1994). 
Anger includes cognitive elements and a tendency for action. Aggression refers to 
behavioral reactions that follow anger. The aim of aggression is to cause destruction 
and damage to persons or objects (Spielberger, 1988). 
Pain-related anger is far less studied than anxiety and depression.  In pain 
patients, the target of the angry feelings can be the pain itself, the healthcare system, 
the employer, insurance companies, family members, etc.  However, among 96 
chronic pain patients the most common target of anger was oneself (Okifuji et 
al., 1999). The majority of the anger and pain studies have utilized Spielberger`s 
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State Trait Anger Expression Inventory  (STAXI) (Spielberger, 1988), a self-report 
questionnaire comprising  six scales: State Anger,  Trait Anger,  Anger Expression-
Out,  Anger Expression-In,  Anger Control-Out,  and Anger Control-In. A revised 
shortened version, STAXI-2, has also been developed and translated into Finnish. 
Some authors have raised questions concerning the validity of the anger expression 
scales.  For example, the anger-in subscales may cover only deliberate anger 
inhibition, excluding the more unconscious parts of the constructs (Burns et al., 
2008). In addition, the model of Spielberger has been criticized for being too narrow 
and	simplified	(Linden	et	al.,	2003).
Anger management style refers to the way in which individuals handle their 
anger. Anger can be expressed outward (anger-out), with angry feelings expressed 
by shouting, arguing, throwing objects, etc.  The opposite style, anger-in, involves 
suppressing and inhibiting the anger. Anger control refers to the ability to control 
angry feelings regardless of the direction of expression (Spielberger et al., 1988)  
Cross-sectional studies have reported an association between anger-out and 
elevated pain responsiveness and pain ratings (Bruehl et al., 2007, Burns et al., 
2007). Anger-out has been associated with greater pain intensity in migraine 
(Materazzo	et	al.,	2000),	fibromyalgia	(Sayar	et	al.,	2004),	and	chronic	low	back	pain	
(Lombardo et al., 2005). In addition, it has been associated with a decreased level 
of functioning (Duckro et al., 1995, Burns et al., 1998).  The opposite management 
style, suppressing anger, has also been associated with higher pain intensity and 
pain ratings (Arena et al., 1997, Materazzo et al., 2000, Nicholson et al., 2003, Sayar 
et al., 2004). Some studies have also reported observations concerning the linkage 
between suppressed anger and depression (Tschannen et al., 1992, Duckro et al., 
1995, Materazzo et al., 2000, Bruehl et al., 2002, Nicholson et al., 2003, Sayar et 
al., 2004). One explanation has been that the possible linking mechanisms are 
more	related	to	a	general	negative	affect	rather	than	specifically	anger	suppression	
(Burns et al., 2008). Individuals with high negative affectivity have a tendency to 
experience marked distress and report high levels of symptoms (Watson et al., 1989).
Compared with healthy controls, chronic pain patients with high inhibited 
anger showed increased muscle tension reactivity in an EMG recording after anger 
induction, suggesting that muscle reactivity could explain partly the association 
between anger and pain (Burns et al., 2006). Another model associated the 
endogenous opioid system with anger.  Impaired opioid function was associated with 
high	anger	expression	in	a	finger	pressure	task	(Bruehl	et	al.,	2007).	Neuroimaging	
studies may provide a linkage between anger and pain.  Several interconnected brain 
regions, such as the amygdala, anterior cingular cortex, prefrontal and orbitofrontal 
cortex, and insula, are involved in the regulation of both conditions (Davidson et 
al., 2000).
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Anger is common in chronic pain, however, the number of current studies 
is limited. Cross-sectional studies have shown an association between anger 
management and the pain experience. Both anger inhibition and anger expression 
outward have been associated with elevated pain intensity. In addition, anger 
inhibition has been related to depressed mood in chronic pain patients.
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3. AIMS OF THE STUDY
The aims of this study were to examine the psychiatric comorbidity related to chronic 
pain using both the diagnostic and dimensional approaches and to assess relations 
and mechanisms between the psychiatric disorders and the pain experience.
Specific	aims	were	as	follows:
1) To investigate the prevalence of mental disorders among chronic pain 
patients and the temporal relationship between the lifetime disorders 
and the onset of pain.
2) To investigate the relationship of the trait-anxiety construct Harm 
Avoidance with pain-related anxiety.
3) To investigate how anger management of chronic pain is related to 
depression.  
4) To assess the dimensional and categorical approaches of depression 
in chronic pain and the differences between the somatic-physical and 
cognitive-emotional symptoms of depression. 
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4.1. STUDY DESIGN AND PARTICIPANTS 
The subjects of this cross-sectional study comprised 100 clinical patients remitted 
for treatment and assessment to the Helsinki University Central Hospital Pain 
Clinic. The clinic is a specialized pain clinic receiving patients from other clinics 
and hospitals in the greater Helsinki area.
The inclusion criteria were chronic pain for at least one year, age 30-60 years, 
fluency	in	the	Finnish	language,	and	willingness	to	participate	in	the	study.	Exclusion	
criteria were malignant pain syndromes, strong opioid medication, psychosis, and 
active drug or alcohol abuse. The recruitment was continued until 100 patients had 
been enrolled.  Participation was suggested to a total of 121 consecutive patients 
during a scheduled visit in the clinic.  The study session was held within 1-3 weeks 
from the visit. Before the session, patients signed an informed consent. Patients 
filled	 in	the	questionnaires	and	were	 interviewed	face-to-face	by	the	researcher	
psychiatrist (PK). The interviews were performed between March 2005 and July 
2006. 
Among	 the	21	patients	not	 included	 in	 the	final	 sample	were	patients	who	
had initially shown willingness but who did not show up, patients who declined 
participation prior to the study session, one patient who interrupted, and two 
patients with a large amount of missing data.  
The study protocol was approved by the Ethics Committee of the Department 
of Surgery, Helsinki University Central Hospital, Finland.
4.2. DATA COLLECTION
4.2.1. PAIN-RELATED ASSESSMENT
The pain-related measures were assessed using the Pain Questionnaire (“Kipukysely”, 
www.suomenkivuntutkimusyhdistys.fi),	 a	 self-administered	questionnaire	used	
routinely in the Pain Clinic.  It contains questions related to treatment of pain, 
onset of pain, localization and duration of pain, demographic data, family and 
work situation, etc.  
The questionnaire includes the visual analog scale (VAS) consisting of a horizontal 
line, with one end (0) indicating no pain and the other end (10) indicating maximal 
pain.  Patients were asked to mark the point on the continuum that represents their 
current level of pain. 
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Pain-related functional disability was measure by a scale comprising 18 items 
describing the pain interference with daily activities such as, lying, sitting, cleaning, 
sexual activities, etc.  Each item has three response options; 1 “not at all”, 2 
“somewhat”, and 3 “much”. A sum score (range 18-54) is calculated, with a higher 
score indicating more severe disability.
The	pain	diagnosis	and	classifications	were	performed	by	the	pain	clinicians	as	
part	of	the	treatment	program.	Pain	diagnoses	were	classified	into	four	etiological	
groups: neuropathic, nociceptive, visceral, or idiopathic pain. In case there were 
several pain conditions, the main presenting pain was chosen as the primary pain.
4.2.2. SELF-REPORT QUESTIONNAIRES
The Beck Depression Inventory (BDI) is a self-administered 21-item scale used to 
assess the current severity of depression. Several versions of BDI exist; the one most 
commonly used is the BDI-IA (Beck et al., 1996a). Each item is rated on four-point 
scale (0 to 3), with possible total score ranging from 0 to 63.  The traditional cut-off 
scores are 0–9: indicating minimal depression, 10–18: indicating mild depression, 
19–29: indicating moderate depression, and 30–63: indicating severe depression 
(Beck et al., 1961).
A number of studies support the validity and other psychometric properties of 
the BDI (Kearns et al., 1982, Beck and Steer, 1984, Varjonen et al., 1997, Steer et 
al., 1999).
The questionnaire included several items related to somatic symptoms of 
depression. Morley et al. (2002) presented a two-factor model of the BDI based 
on	a	confirmatory	 factor	analysis	performed	on	a	 large	sample	of	chronic	pain	
patients. This model includes two subscales. 
The	first	subscale	“Negative	View	of	Self”	(6	items,	range	0–18)	includes	the	
items of failure, guilt, self-blame, self-dislike, punishment, and body image change. 
 The second subscale “Somatic and Physical Function” (7 items, range 0–21) 
includes	the	 items	of	work	difficulty,	 loss	of	appetite,	 loss	of	 libido,	 fatigability,	
insomnia, somatic preoccupation, and social withdrawal. 
The remaining items (sadness, pessimism, dissatisfaction, suicidal ideas, crying, 
irritability, indecisiveness, and weight loss) did not form a coherent factor.  The 
two-factor	model	showed	stability	and	fitted	the	data	better	than	the	other	tested	
models (Morley et al., 2002).  
Regarding	the	data	of	the	present	study,	a	confirmatory	factor	analysis	(CFA)	
was	performed	to	determine	whether	the	data	fitted	the	factor	model.	
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The State Trait Anger Expression Inventory, revised version (STAXI-2) (Spielberger, 
1999) is a questionnaire measuring the experience, expression, and control of anger. 
It comprises six scales: State Anger, Trait Anger, Anger Expression-Out, Anger 
Expression-In,	Anger	Control-Out,	and	Anger	Control-In,	as	well	as	five	subscales.	
An additional Anger Expression Index measures the total anger expression derived 
from anger control and expression scales. The Inventory has been translated into 
Finnish.  The psychometric properties of STAXI have shown relatively high validity 
and reliability (Spielberger, 1999, Gollwitzer et al., 2005).
 In this study, two scales were used to describe the anger management style: 
Anger Expression-In (Anger Inhibition), which describes the suppression of angry 
feelings (8 items, range 8-32), and Anger Expression-Out (8 items, range 8-32), 
which describes the extent to which a person expresses angry feelings outwards. 
The psychometric properties have been estimated in several samples (Spielberger 
et al., 1988, Spielberger, 1999, Borteyrou et al., 2008).
The Harm Avoidance (HA) scale is one of the four temperament scales of the 
Temperament and Character Inventory (TCI) (Cloninger et al. 1994), a self-
administered questionnaire based on the temperament model of Robert Cloninger 
(Cloninger et al. 1993). The Finnish translation of the version with 240 true/false 
questions was used. The factor structure, internal validity, and test-retest reliability 
of the TCI have been previously demonstrated in both general and psychiatric 
populations (Brandstrom et al., 1998, Pelissolo and Lepine, 2000, Miettunen et 
al., 2004).  The psychometric properties of the Finnish version indicated good 
functioning of the model (Miettunen et al., 2004). 
The HA scale comprises four subscales describing different aspects of the anxiety 
trait:
HA1 Anticipatory Worry (11 items, e.g. “Usually I am more worried than most people that 
something might go wrong in the future.”),
HA2 Fear of Uncertainty (7 items, e.g. “I often feel tense and worried in unfamiliar situations, 
even when others feel there is little to worry about.”),
HA3 Shyness with Strangers (8 items, e.g. “I often avoid meeting strangers because I lack 
confidence with people I do not know.”),
HA4 Fatigability (9 items, e.g. “I have less energy and get tired more quickly than most 
people.”).
The Pain Anxiety Symptom Scale-20 (PASS-20) (McCracken and Dhingra, 2002) is 
a shortened version of the original PASS (McCracken et al., 1992). It measures fear, 
anxiety,	and	worries	specific	to	pain.	It	is	a	self-report	instrument	consisting	of	20	
questions	and	a	six-point	Likert-scale	reflecting	four	facets	of	pain-related	anxiety.	
The Fearfulness subscale describes fearful appraisals and interpretations about 
pain (e.g. “When I feel pain, I think I might be seriously ill.”).  
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The	Cognitive	subscale	describes	cognitive	anxiety	and	difficulties	in	concentrating	
(e.g.” I can’t think straight when in pain.”). 
The Escape/Avoidance subscale describes avoidant behavior and reactions as a 
response to pain (e.g. “I go immediately to bed when I feel severe pain.”). 
The Physiological anxiety subscale describes physiological symptoms of anxiety 
(e.g. “Pain seems to cause my heart to pound and race.”).  
The PASS-20 scales have strong positive correlations with the scales of the 
original PASS and have shown stability concerning the four-factor model. The 
psychometric properties of the questionnaire, its validity, internal consistency, and 
reliability have been found to be good to excellent (McCracken and Dhingra, 2002, 
Coons et al., 2004). The Finnish version of PASS-20 was used in the study. In the 
text,	the	term	PASS	denotes	PASS-20	if	not	otherwise	specified.
4.2.3. PSYCHIATRIC INTERVIEW
The clinician version of the Structured Clinical Interview for DSM-IV (SCID-CV) was 
used to diagnose Axis 1 disorders (First et al., 1996).  The Axis 1 mental diagnoses 
were assessed over the lifetime, the past month, and the past 12 months.  Because 
the clinician version has a summarized form for the anxiety disorders, this section 
was	modified	to	be	equivalent	to	the	diagnostic	criteria	of	the	research	version.	
Somatization disorder, undifferentiated somatoform disorder, and hypochondriasis 
were omitted due to validity and reliability issues. The onset of the disorders was 
assessed according to the recollection of the patient. The temporal association 
between the onset of pain and the onset of the psychiatric disorders was assessed 
on the basis of the Pain Questionnaire.  The researcher psychiatrist (PK) had 
participated in a SCID training workshop organized by the Department of Psychiatry, 
Helsinki University Central Hospital.
4.3. STATISTICAL ANALYSES
The data were analyzed using SPSS, PASW, and AMOS (Arbuckle and Wothke, 
1999) software.
The parametric and non-parametric statistical methods were used when 
appropriate. Univariate analyses included Student’s t-test, Mann-Whitney test, 
Kruskal-Wallis	test,	and	Pearson’s	correlation	coefficient.	 	Cronbach’s	alpha	was	
applied to assess internal consistency. Missing values were replaced with the mean 
score of the variable. The proportion of the missing values concerning the self-report 
questionnaire variables was low, varying between 1% and 3%.
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In the statistical analyses concerning multiple comparisons, the p-value 
correction was performed either using the Bonferroni correction or in the case 
of multiple correlated variables according to the recommendations by Li and Ji 
(Nyholt, 2004, Li and Ji, 2005). Linear and logistic regression models were used 
to examine the relationships between variables.   
The effect of pain severity on the regression analyses was taken into account by 
using the approach recommended by Aiken and West (1991).  Interaction variables 
were	created	based	on	significant	predictor	variables	and	pain	severity.	The	influence	
of pain was tested by forming two groups based on the median split of the pain 
intensity VAS.  The results were illustrated by plotting the regression curves at 
+1SD, mean, and -1SD values of the pain intensity variable. This approach was 
used when assessing the effect of the anger management style on depression and 
the connection between Harm Avoidance and pain-related anxiety.  
A	confirmatory	factor	analysis	using	the	AMOS	program	(Arbuckle	and	Wothke,	
1999)	was	used	to	assess	whether	the	present	BDI	data	fitted	the	BDI	model	by	
Morley, which was used in the study. The methods of estimation were the Chi-square 
test and the root mean square error of approximation (RMSEA).
4.4. ETHICAL ASPECTS
The studies were conducted in accordance with the ethical principles of the 
Declaration of Helsinki. The study protocol was approved by the Ethics Committee 
of Helsinki University Central Hospital. Before entering the study, all subjects gave 
their written informed consent. 
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5. Results
5. RESULTS
5.1. CHARACTERISTICS OF PATIENTS
5.1.1. SOCIODEMOGRAPHIC CHARACTERISTICS
Females comprised 62% of the patients. The mean age of patients was 47.9 years 
(SD 7.3, range 30–60). The mean age of females was 47.0 years (SD 7.5) and of 
males 49.4 years (SD 6.8). Of all patients, 60% were married or living with a partner 
and 16% lived alone. Regarding education, 21% of patients had a university level 
education, 54% had a vocational education, and 25% had no professional education. 
Altogether, 39% were on sick leave, 39% were employed or studying, 12% were 
pensioners, and 4% were unemployed. 
5.1.2. PAIN CHARACTERISTICS
The median duration of chronic pain was 4 years (range 1-44).  Sixteen percent 
of patients reported that they had had pain for more than 10 years.  The majority 
(61%)	had	pain	duration	between	one	and	five	years.	The	mean	current	pain	score	
using the Visual Analog Scale (VAS) was 6.0 (SD 2.1), ranging from 0 to 10.0 cm. 
Compared with women, men reported a higher level of current pain (6.6 (SD 1.8) 
vs. 5.6 (SD 2.2), t (98) = 2.47, p= 0.015). 
Neuropathic pain was the most common (49%) pain category. The most common 
neuropathic disorders were peripheral neuropathies, spinal cord-related pain 
disorders, and pain related to central nervous system conditions such as multiple 
sclerosis or stroke. Of patients, 21% had nociceptive pain, the majority of which was 
related to osteoarthritic or other connective tissue pain conditions.  A further 5% 
had visceral pain originating from internal organs such as the pancreas, bladder, 
uterus, or bowels.  Idiopathic pain accounted for 25% of pain. This group included 
such	pain	conditions	as	fibromyalgia,	temporomandibular	disorder,	vulvodynia,	and	
pain of unknown etiology.  All of the patients had at least one regular medication 
for chronic pain. Tricyclic antidepressants were used by 48% of patients.  Other 
antidepressants (mainly SSRIs or SNRIs) were used by 56%. Only 17% of patients 
were without any antidepressants.
43
5.1.3. CHARACTERISTICS OF DIMENSIONAL VARIABLES
Descriptive statistics of the psychological variables are presented in Table 3.  The 
internal consistencies of the dimensional variables were acceptable.  Some of the 
lower Cronbach alpha levels may be related to the low numbers of items in the 
variable.  
Table 3. Descriptive statistics for the dimensional variables of the study.
Minimum Maximum Mean SD Cronbach alpha
BDI  sum score, range 0–63 (21 items) 1.0 46.0 17.4 10.3 0.90
BDI, Negative View of Self, range 0–18 
(6 items)
0.0 18.0 3.9 4.0 0.84
BDI, Somatic and Physical Function, 
range 0–21 (7 items)
1.0 20.0 7.2 3.5 0.73
Anger Expression-In, range 8–32  
(8 items)
8.0 30.0 20.0 4.3 0.69
Anger Expression-Out, range 8–32  
(8 items)
8.0 31.0 17.6 4.3 0.81
Harm Avoidance, range 0–35 (35 items) 2.0 34.0 17.0 6.9 0.88
HA1 Anticipatory Worry, range 0–11  
(11 items)
1.0 11.0 4.8 2.5 0.73
HA2 Fear of Uncertainty, range 0–7  
(7 items)
0.0 7.0 3.7 1.9 0.66
HA3 Shyness with Strangers, range 0–8 
(8 items)
0.0 8.0 2.9 2.2 0.75
HA4 Fatigability, range 0–9 (9 items) 0.0 9.0 5.7 2.2. 0.72
PASS-20 total, range 0–100 8.0 95.0 47.4 17.9 0.91
PASS Fearfulness, range 0–25 (5 items) 0.0 22.0 10.2 5.3 0.77
PASS Escape-avoidance, range 0–25  
(5 items)
2.0 24.0 12.5 5.2 0.76
PASS Cognitive Anxiety, range 0–25  
(5 items)
4.0 25.0 15.5. 5.1 0.82
PASS Physiological Anxiety, range 0–25 
(5 items)
0.0 25.0 9.2 5.3 0.72
Pain Disability score, range 18–54  
(18 items)
22.0 54.0 40.1 7.1 0.87
Current pain score, Visual Analog Scale 
(0–10.0)
6.0 10.0 9.9 2.1 -
PASS= Pain Anxiety Symptom Scale, BDI=Beck Depression Inventory, 
Missing data:  Harm Avoidance 1/100, HA2  1/100, PASS 1/100, PASS subscales 1/100, Pain 
disability 3/100
The zero-order correlations of the main dimensional variables are presented in 
Table 4.  Current pain intensity did not correlate with any of the variables, except 
for the BDI physical and somatic function scale. Harm Avoidance had a positive 
correlation with the scales related to negative emotions such as pain-related anxiety, 
inhibition of anger, and the BDI scales.
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Table 4. Intercorrelations of the main dimensional variables.
Current 
pain
BDI 
sum 
score
BDI 
Negative 
view
BDI Somatic 
and 
physical 
function
Harm 
Avoidance 
sum score
PASS 
sum 
score
Anger 
inhibition 
Anger 
expression-
Out
Current 
pain
1.00
BDI sum 
score
0.16 1.00
BDI 
Negative 
view
0.07 0.84** 1.00
BDI 
Somatic 
and 
physical 
function
0.25* 0.87** 0.54** 1.00
Harm 
Avoidance 
sum score
0.19 0.47** 0.45** 0.38** 1.00
PASS sum 
score
0.04 0.43** .29** 0.46** 0.32** 1.00
Anger 
inhibition
0.08 0.51** 0.44** 0.39** 0.30** 0.24* 1.00
Anger 
expression-
Out
0.14 0.15 0.12 0.13 0.14 0.09 0.09 1.00
 
n=100, PASS= Pain Anxiety Symptom Scale, BDI= Beck Depression Inventory
* correlation significant at p< 0.05 (two-tailed)
** correlation significant at p< 0.01 (two-tailed)
5.2. PSYCHIATRIC DISORDERS IN CHRONIC PAIN PATIENTS  
 (STUDY I)
During the lifetime 75% of subjects had had at least one Axis 1 disorder. The most 
common disorders were major depressive disorder (MDD) and anxiety disorders. 
Any 12-month DSM-IV diagnosis was present in 59% of patients. The prevalence of 
MDD	in	the	preceding	12	months	was	37%	in	the	whole	sample,	with	no	significant	
gender	difference	(females	38.7%	vs.	males	34.2%).	 	Twenty-five	percent	of	 the	
patients had at least one anxiety disorder (females 29.0% vs. males 18.4%, ns). 
All	of	the	specific	anxiety	disorder	categories	of	DSM-IV	were	represented	among	
the	patients,	with	 specific	phobias	 and	PTSD	being	 the	most	 common	during	
the lifetime. During the past 12 months the most common psychiatric disorders 
were	generalized	anxiety	disorder	(GAD)	and	specific	phobias.	The	prevalence	of	
substance use disorders was 17% over the lifetime and 12% over the past 12 months. 
These rates include both abuse and dependence. The prevalences are high in view 
of the fact that active abuse problems were among the exclusion criteria of the 
study. Table 5 presents the prevalences of Axis I disorders in the past 12 months 
and over the lifetime.
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When comparing the time of onset of pain and the psychiatric disorders, the 
majority (77%) of the anxiety disorders occurred before the onset of pain. This 
finding	was	consistent	across	the	various	anxiety	disorder	categories.	Concerning	
depression, MDD followed onset of pain in 65% of cases (Table 5).
In	the	logistic	regression	analysis,	current	pain	severity	(VAS)	was	significantly	
associated with presence of past 12-month mood disorders (OR= 1.29, 95% CI 
1.02-1.62), anxiety disorders (OR= 1.46, 95% CI 1.09-1.96), and DSM-IV disorders 
(OR=1.34, 95% CI 1.06-1.70). Sociodemographic characteristics, education, work, 
and marital status were not associated with psychiatric disorders in the regression 
analyses.
The length of the pain symptom was also associated with anxiety (OR=1.07, 
95% CI 1.00-1.15) and depression (OR= 1.08, 95% CI 1.01-1.16). In contrast to 
other pain classes, having neuropathic pain was not associated with psychiatric 
morbidity, neither was having more than one pain.
 The current pain VAS was highest among patients with both mood and anxiety 
disorders (6.9, SD 2.0, n=16) during the past 12 months. The difference was 
significant	relative	to	those	with	neither	disorder	(5.5,	SD	1.8,	n=46,	p=0.010),	
but	non-significant	relative	to	those	with	either	mood	disorder	(6.2,	SD	2.5,	n=29,	
p=0.31) or anxiety disorder (6.3, SD 2.1, n=9, p= 0.52). 
Table 5. Prevalence of past 12-month and lifetime mental disorders and onset of pain in 100 chronic 
pain patients. 
12-month
%
Lifetime
%
Lifetime onset before pain
n (%)
Any axis I disorder 59 75 -
Two or more axis I disorders 22 39 -
Any mood disorder 45 59 25 (37%)
Major depressive disorder 37 54 19 (35%)
Dysthymic disorder 11 11 4 (36%)
Bipolar disorder 2 2 2 (100%)
Any anxiety disorder 25 39 37 (77%)
Panic disorder 2 6 5 (83%)
Agoraphobia 1 2 1 (50%)
Specific phobia 8 11 9 (82%)
Social phobia 5 7 6 (86%)
Generalized anxiety disorder 8 8 5 (63%)
Obsessive-compulsive disorder 2 2 2 (100%)
Post-traumatic stress disorder 2 12 9 (75%)
Substance use disorder 16 17 nk
Eating disorder 0 2 nk 
nk not known
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5.3. HARM AVOIDANCE AND PAIN-RELATED ANXIETY  
 (STUDY II)
The HA score correlated positively with the PASS total score (r= 0.32, p< 0.01) 
(Table 4) and two of its subscales, PASS physiological (r=0. 32) and PASS fearfulness 
(r=0. 34) (both p< 0.01). With the remaining two subscales, the correlation was not 
significant.		Analyzing	separately	the	subscales	of	Harm	Avoidance,	HA4	Fatigability	
had the strongest association with the PASS scales (correlations ranging between 
r=0.394, p< 0.001, and r=0.480, p< 0.001). The current pain severity did not 
correlate	significantly	with	any	of	the	Harm	Avoidance	or	PASS	scales	(Table	4).
The association between HA and PASS was present also in the multiple regression 
analyses (Table 6). Adjusted for gender, age, and pain severity, the Harm Avoidance 
total score was associated with the PASS total score.  After adding the BDI sum 
score	to	the	equations,	 the	association	 lost	 its	significance.	 	Similar	results	were	
detected when using the PASS subscales as dependent variables.
Table 6. Regression analyses with PASS as a dependent variable and pain severity, HA scales, 
and BDI as independent variables (n=100).
Model 1a
βb t p βb t p
Current pain -0.016 -0.155 0.877 -0.059 -0.579 0.564
HA 0.328 3.278 0.001 0.163 1.525 0.131
BDI 0.362 3.389 0.001
R² adjusted 0.067 0.161
Model 2a
Current pain -0.024 - 0.246 0.806 - 0.050 - 0.507 0.614
HA1 Anticipatory 
Worry
0.231 1.843 0.069 0.153 1.149 0.254
HA2 Fear of 
Uncertainty
- 0.194 -1.663 0.100 - 0.121 - 0.975 0.332
HA3 Shyness with 
Strangers
- 0.078 -0.648 0.519 -0.108 -0.901 0.370
HA4 Fatigability 0.465 4.208 <0.001 0.391 3.312 0.001
BDI 0.196 1.650 0.103
R² adjusted 0.225 0.239
 
PASS= Pain Anxiety Symptom Scale, BDI=Beck Depression Inventory, HA= Harm Avoidance    
a adjusted for age and gender 
b  standardized coefficient
47
This	finding	suggests	that	the	association	is	influenced	by	the	BDI	score.	The	
correlation analysis showed that the Harm Avoidance score and the BDI score 
had a positive correlation (r=0. 47, p< 0.01) (Table 4), indicating a relationship 
between the constructs. When the analysis was performed using the subscales of 
HA as independent variables instead of total HA score, the association of HA4 
Fatigability	remained	significant	even	after	adding	the	BDI	score	to	the	equation	
(Table	6).	Similarly,	the	HA1	Anticipatory	Worry	subscale	remained	significant	on	
the PASS-Fearfulness scale (β= 0.285, t= 2.10, p=0.039).
The relation of HA with PASS was further studied by assessing the effect of 
pain severity on the association.  Concerning the HA total score x pain severity, 
no interaction effect was present. However, an interaction existed between HA4 
Fatigability and pain severity (p=0.020). The median split was used to divide patients 
into low and high pain severity groups. The association between HA4 and PASS 
was stronger in the high pain severity group than in the low pain severity group. 
Pain severity acted as a moderator between the variables (Figure 2).
Figure 2. Influence of pain severity on the relationship between Harm Avoidance subscale HA4 
Fatigability and pain-related anxiety (PASS). 
 
Pain at mean    
Pain at 1 SD above mean   
Pain at 1 SD below mean 
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5.4. ANGER MANAGEMENT AND DEPRESSION (STUDY III)
A	significant	positive	correlation	existed	between	Anger	Expression-In	and	the	BDI	
depression	scales,	the	correlations	coefficients	varying	between	0.39	and	0.51.			The	
score for the opposite anger management style, Anger Expression-Out, did not 
correlate	significantly	with	any	of	the	BDI	scores.	The	current	pain	severity	did	
not correlate with either of the anger management scales. Anger inhibition had a 
weak	positive	correlation	also	with	other	scales	reflecting	negative	affectivity,	i.e.	
Harm Avoidance (r= 0.30, p< 0.01) and PASS (pain-related anxiety) (r=0.24, p< 
0.05) (Table 4).
The strength of the relationship between Anger Expression-In and the BDI 
Physical and Somatic scale was dependent on the pain severity. Higher pain severity 
yielded a stronger association between the variables (interaction term p=0.019) 
(Figure 3). In other words, pain patients with a tendency to inhibit their angry 
feelings had more physical symptoms of depression when the pain experience was 
stronger compared with those who experienced milder pain. Concerning the BDI 
Negative View of Self scale, no such interaction was present.
Figure 3. Influence of pain severity on the relationship between the physical and somatic symptoms of 
depression and inhibited anger management. 
 
Pain at mean     
Pain at 1 SD above mean   
Pain at 1 SD below mean 
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5.5. SOMATIC AND COGNITIVE-EMOTIONAL ITEMS OF BDI   
 COMPARED WITH DSM-IV MAJOR DEPRESSIVE DISORDER  
 (STUDY IV)
The	data	of	 the	BDI	quesionnaire	were	analyzed	using	the	confirmatory	 factor	
analysis in order to compare it with the two-factor model presented by Morley. 
The	fit	of	the	data	to	the	Morley	model	was	acceptable.	The	data	fit	well	(Chi-square	
74.4,	with	64	degrees	of	 freedom	provided	a	non-significant	p-value	(0.18),	and	
a RMSEA (Root mean square error of approximation measures discrepancy per 
degree of freedom) of 0.041 (95% CI 0.00-0.075)), when a value of less than 0.05 
is	taken	to	indicate	a	good	fit.	The	result	indicated	that	the	model	could	be	utilized	
in the analysis.
The	prevalence	of	the	patients	fulfilling	the	criteria	of	current	MDD	(	1	month)	
was	20%.	These	patients	were	compared	with	the	80	patients	not	fullfilling	the	
current MDD criteria. These groups did not differ regarding age, gender, education, 
working or social status, or time since pain onset.
Relative to patients without MDD,  those with MDD had higher BDI total score 
29.0 (SD 9.9) range 10.0-46.0  vs.   14.5 (SD 8.1) range 1-39 , t -6.82, p<0 .001), 
BDI Negative View of Self score 7.1 (SD 4.9) range 0-18.0 vs. 3.1 (SD 3.4 ) range 
0-13.0 , t -3.51  p=0.002), and BDI Somatic and Physical function score 11.2 (SD 
4.0)  range 2.0-20.0  vs. 6.2 (SD 2.6) range 1.0 -14.0 ,  t -6.86, p< 0.001).  Patients 
with MDD also had higher current  pain severity VAS 7.1 (SD 1.6) vs. 5.7 (SD 2.1), 
t -2.82, p< 0.006).   However,  the pain disability score did not differ between 
patients with and without MDD. 
The comparisions between pain patients with and without MDD were performed 
also item by item (21 items) (Table 7). According to the recommendations for 
correlated	variables,	the	significance	level	was	set	to	p<	0.0034.	Using	the	Mann-
Whitney median rank test in the comparison , 11 of the 21 items were  different 
between the groups.  Patients with MDD had higher scores  in  items representing 
the somatic/physical function, such as social withdrawal, loss of appetite, and libido, 
as well as several cognitive-emotional items, which were not included in the factor 
model,  such as irritability, sadness, guilt, or suicidal ideas. The two least differing 
items between the groups were  insomnia and weight loss. 
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Table 7. Comparing BDI items (according to the two-factor model of BDI) between patients with 
(n=20) and without (n=80) diagnosis of current MDD.
Mann-Whitney 
U-test
Z pa Factor in BDI model
BDI 5 Guilt 474.00 -3.27 0.001* BDI Negative view of self
BDI 7 Self-dislike 529.50 -2.78 0.006 BDI Negative view of self
BDI 14 Body image change 515.00 -2.65 0.008 BDI Negative view of self
BDI 6 Punishment 572.50 -2.62 0.009 BDI Negative view of self
BDI 8 Self-accusation 554.00 -2.30 0.022 BDI Negative view of self
BDI 3 Sense of failure 589.50 -2.09 0.037 BDI Negative view of self
BDI 12 Social withdrawal 264.00 -5.06 <0.001* BDI Somatic/physical function
BDI 18 Loss of appetite 403.50 -4.18 <0.001* BDI Somatic/physical function
BDI 21 Loss of libido 348.50 -4.07 <0.001* BDI Somatic/physical function
BDI 17 Fatigability 421.50 -3.64 <0.001* BDI Somatic/physical function
BDI 15 Work difficulty 524.50 -2.76 0.006 BDI Somatic/physical function
BDI 20 Somatic 
preoccupation
600.50 -2.09 0.037 BDI Somatic/physical function
BDI 16 Insomnia 631.00 -1.60 0.11 BDI Somatic/physical function
BDI 11 Irritability 349.00 -4.51 <0.001* Item not in model
BDI 13 Indecisiveness 339.00 -4.25 <0.001* Item not in model
BDI 9 Suicidal ideas 386.00 -4.11 <0.001* Item not in model
BDI 4 Dissatisfaction 414.00 -3.63 <0.001* Item not in model
BDI 2 Pessimism 402.50 -3.61 <0.001* Item not in model
BDI 1 Sadness 452.00 -3.28 0.001* Item not in model
BDI 10 Crying 574.00 -2.21 0.027 Item not in model
BDI 19 Weight loss 627.00 -1.77 0.076 Item not in model
a Significance level adjusted to p < 0.0034 according to recommendations concerning correlated 
variables (Li and Ji, 2005; Nyholt, 2004)
In multiple logistic regression analysis after controlling for gender, age, and 
pain	severity,	MDD	was	significantly	associated	with	both	the	BDI	Negative	View	of	
Self  (OR 1.25, 95% CI 1.09-1.44, p=0.002) and the BDI Somatic/Physical function 
(OR 1.83, 95% CI 1.33-2.51, p= 0.0002) subscales when only one the subscales was 
entered into the equation. However, when both subscales were entered together into 
the	same	equation	(Equation	2),	the	association	was	significant	only	with	the	BDI	
Somatic/Physical function scale (OR 1.69, 95% CI 1.23-2.31, p=0.001) (Table 8).
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Table 8.  Logistic regression analysis with current major depressive disorder as a dependent variable 
(n=100).
Equation 1 Equation 2
Variable Ba S.E. Wald p OR (95%CI) Ba S.E. Wald p OR (95%CI)
Age 0.01 0.04 0.12  0.72 1.01  (0.94-1.10) 0.03 0.05 0.36 0.55
1.03  
(0.93-1.14)
Gender 0.75 0.61 1.50 0.22 2.11  (0.64-6.97) 1.60 0.86 3.45 0.063
4.94  
(0.92-26.7)
Current 
pain 
severity
0.50 0.18 7.76 0.005
1.64  
(1.16-2.33) 0.47 0.24 3.93 0.047
1.60  
(1.01-2.53)
BDI 
Negative 
view of 
self
0.06 0.09 0.37 0.54
1.06  
(0.88-1.27)
BDI 
Somatic/ 
physical 
function
0.52 0.16 10.5 0.001
1.69  
(1.23-2.31)
Pain 
disability -0.04 0.06 0.36 0.55
0.97  
(0.86-1.08)
Pseudo 
R2 0.097 0.35
  
a   standardized coefficent, S.E. standard error, OR Odds ratio
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6. DISCUSSION
6.1. MAIN FINDINGS
In the clinical sample of chronic pain patients, the prevalence of psychiatric 
comorbidity	was	high.	The	majority,	75%,	of	the	patients	fulfilled	the	criteria	for	at	
least one lifetime psychiatric disorder.  The patients had a wide range of disorders, 
the most common of which were MDD and anxiety disorders. The majority of the 
anxiety disorders were present before onset of pain.   Thus, the temporal relationship 
excludes pain having a direct causal effect on anxiety disorders. Concerning 
depression, the pattern of the temporal relationship was different. In about 60% 
of patients, depression followed the onset of pain. During the past 12 months the 
prevalence of MDD was 37% and the prevalence of anxiety disorders 25%. Compared 
with the prevalences of depression and anxiety in the general adult population in 
Finland (Pirkola et al. 2005), the prevalences here are six times higher. 
The temperament trait Harm Avoidance was associated with pain-related anxiety 
symptoms. The association weakened after the effect of depression was controlled. 
In addition, the strength of the association was dependent on pain severity. Patients 
with higher pain severity had a stronger association between the HA4 Fatigability 
subscale and pain-related anxiety. In patients with milder pain, the association was 
weaker. A similar type of pain severity-dependent interaction was detected between 
anger inhibition and the somatic symptoms of depression. However, no interaction 
effect existed between anger inhibition and pain concerning the cognitive-emotional 
symptoms of BDI. The BDI factor model of Morley et al. (2002) was used here in 
order to differentiate the cognitive-emotional and the somatic-physical items of the 
questionnaire.   When the two factors of Morley’s BDI model were compared between 
patients with and without a DSM-IV-derived diagnosis of MDD, the depressed 
patients scored higher in both factors. However, the somatic-physiological items 
were more strongly related to the diagnosis of MDD. 
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6.2. RESULTS IN RELATION TO PREVIOUS STUDIES
6.2.1. PREVALENCE OF DEPRESSION AND ANXIETY COMPARED WITH OTHER  
 STUDIES USING DSM 
The prevalence of depression and anxiety in this study was high, consistent with the 
findings	of	several	previous	studies	performed	in	pain	clinic	population	samples.	
The tertiary pain clinic patients represent the most complicated portion of chronic 
pain patients, with enhanced functional disability and past treatment failures, 
which may explain the reporting of high prevalences of mental comorbidity.  The 
generalizability of the results is thus limited. Compared with more recently published 
studies (Gerhardt et al., 2011, Reme et al., 2011, Radat et al., 2013), the prevalences 
of mood and anxiety disorders were markedly higher in this study.   
The prevalence of psychiatric disorders may, however, vary considerably between 
different studies, even if the studies have used structured diagnostic methods based 
on DSM criteria (Table 1).  The large variability is particularly present in the disorder 
categories of dysthymia, ranging between 1%  (Radat et al., 2013) and 23% (Fishbain 
et al., 1986), and GAD, ranging between 5% (Arnold et al., 2006) and 70% (Verri et 
al., 1998).  In the present study, the prevalences of certain anxiety disorders, such 
as PTSD, OCD, and social phobia, were generally in line with earlier studies (Table 
1).  The greater variability concerning the prevalences of GAD and panic disorder 
may be related to the symptom overlap phenomenon. Despite using structured 
psychiatric	methodologies,	defining	the	boundaries	between	psychiatric	disorders	
and chronic pain requires subjective interpretation.  The interpretation is likely to 
be	more	difficult	in	disorders	that	have	overlapping	symptoms	with	chronic	pain,	
e.g. muscle tension or arousal, typical in GAD and panic disorder.  The variations 
in pain intensity may also affect the diagnostic process. Severe pain causes more 
arousal, tension, and bodily symptoms.
Another source of the variability is the heterogeneity of pain patients. Some 
studies	may	concentrate	on	specific	pain	patients	such	as	neuropathic	pain	patients	
(Radat	et	al.,	2013)	or	fibromyalgia	patients	(Arnold	et	al.	2006).	Neuropathic	pain	
being more localized in nature has been associated with less emotional symptoms 
than	fibromyalgia,	which	is	a	more	generalized	pain	(Gormsen	et	al.,	2010).	The	
current study resembled most pain clinic studies by having a heterogeneous patient 
sample with several types of pain, including idiopathic pain. 
The	definitions	of	chronic	pain	may	vary	between	the	studies.	According	to	
the	most	usual	definitions,	chronic	pain	 lasts	 longer	 than	three	or	six	months.	
In the present study, the time inclusion criterion was one year, and the median 
duration of pain was four years. The psychological symptoms related to pain may 
vary depending on the duration of pain. Gatchel speculated that a longer duration 
of pain may be associated with a higher prevalence of depression relative to the 
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reactive anxiety and fear typical of more acute pain (Gatchel et al., 1996). Considering 
the long duration of pain in our study, one may expect that the acute anxiety and 
adjustment reactions have declined. 
In addition to depression and anxiety disorders, a structured assessment 
methodology, such as the SCID interview, may reveal also more rare disorders, 
e.g. bipolar disorder or obsessive compulsive disorder, which may be clinically 
important.	Bipolar	disorder	has	seldom	been	explored	in	related	studies	in	the	field	
(Arnold et al., 2006, Radat et al., 2013). The clinical importance of a psychiatric 
diagnosis in chronic pain patients is related not only to its impact on the treatment 
outcome but also to the selection of pharmacological treatment options. Tricyclic 
antidepressants and other double-acting antidepressants are widely used in chronic 
pain,	also	as	first-line	treatment	options,	which	may	complicate	the	management	
of bipolar disorder. 
6.2.2. ANXIETY, DEPRESSION, AND THE TEMPORAL RELATIONSHIP WITH   
 CHRONIC PAIN
The mechanisms underlying the association between chronic pain and psychiatric 
comorbidities are unclear. Analyzing the temporal relationship between the 
conditions	can	shed	some	light	on	the	question	of	causality.	The	finding	that	anxiety	
disorders precede pain onset has been reported in two earlier cross-sectional studies 
(citations). However, Polatin and colleagues (1993) found the prevalence of anxiety 
disorders among 200 back pain patients to be relatively low and similar to that in 
the normal population. In the other study (citation), 87% of 70 PTSD diagnoses 
preceded pain onset, whereas only 46% of the 50 panic disorder cases preceded 
pain. Other anxiety disorders were not registered (Dersh et al., 2007b). These results 
resemble	our	findings.	As	the	studies	are	all	cross-sectional,	with	the	information	on	
other disorders based on patient recollection, the results must merely be considered 
as estimates. To date, prospective studies concerning the onset of anxiety disorders 
related to pain have not been published. Regarding depression, prospective studies 
have supported a reciprocal pattern considering the risk factor function as well as the 
temporal relationship, with depression preceding or following chronic pain onset. 
6.2.3. ANGER AND PAIN 
The number of studies on pain and anger is relatively low compared with anxiety 
and depression.   Regarding the DSM, anger is mentioned only occasionally 
among the criteria of various disorders.  Aggression or irritability   belongs to the 
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symptom criteria of categories such as PTSD, dysthymia, or borderline and antisocial 
personality disorders (American Psychiatric Association, 1994, American Psychiatric 
Association, 2013). The DSM category “Intermittent Explosive Disorder” includes 
verbal and behavioral aggression among the diagnostic criteria, but the diagnosis 
is seldom used in practice or in research. 
The	present	study	confirmed	the	positive	correlation	between	anger	inhibition	
and depression presented by several previous studies (Tschannen et al., 1992, Duckro 
et al., 1995, Materazzo et al., 2000). Analyzing separately the two subscales of the 
BDI showed that anger inhibition correlated with both the cognitive-emotional and 
somatic-physical	symptoms	of	depression.	An	interesting	finding	is	the	influence	of	
pain severity on the association between anger inhibition and the somatic-physical 
signs	of	depression.	The	finding	resembles	 the	earlier-mentioned	finding	of	an	
association of increased muscle reactivity with pain in patients with a high level 
of	anger-in	(Burns	et	al.,	2006).	The	finding	is	also	associated	distantly	with	the	
psychodynamic approach-based ideas of Engel that link emotion suppression to 
bodily	symptoms	and	pain	(Engel,	1959).			However,	the	interaction	finding	may	
also	 reflect	 the	dimensional	 characters	of	 the	constructs	and	 their	overlapping	
boundaries. When the symptoms are more intense, they become more fused with 
each other.
6.2.4. HARM AVOIDANCE AND PAIN-RELATED ANXIETY
To our knowledge, the association between Harm Avoidance (HA) and pain-related 
anxiety (PASS) has not been previously tested. The positive correlation between 
the variables is in line with the numerous studies showing a positive association 
between HA and anxiety disorders in general (Miettunen and Raevuori, 2012). 
High	HA	relative	to	controls	has	been	a	constant	finding	in	studies	among	chronic	
pain patients (Malmgren-Olsson et al., 2006, Conrad et al., 2007, Mazza et al., 
2009). However, lack of healthy controls in our study prevents such an evaluation. 
Considering	 the	 state	 effect,	 the	 association	 became	 less	 significant	 after	 the	
effect of depressive symptoms in the analysis. One possible explanation can be 
the dimensionality and overlap between the constructs of anxiety and depression 
(Brown and Barlow, 2009).  When the subscales of HA were analyzed separately, 
the HA4 Fatigability subscale showed the strongest association with pain-related 
anxiety, even after controlling the state effect of depression.  Previous studies in 
chronic pain patients have shown that the elevation of the HA level has been more 
clear in the HA4 and HA1 subscales than in the other two subscales  (Malmgren-
Olsson et al., 2006, Conrad et al., 2007, Lundberg et al., 2009).  In a recent brain 
imaging study, the same HA4 subscale as well as the HA2 subscale were associated 
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with low opioid receptor availability in the brain areas related to anxiety regulation. 
The authors suggested that a tendency to negative affectivity could parallel the lower 
endogenous opioid activity in the affective brain areas (Tuominen et al., 2012). 
Elevated HA has also been associated with better responsiveness to opioids. A high 
level of HA in healthy volunteers was associated with higher sensitivity to morphine 
in the cold pressure test (Pud et al., 2006).  
6.2.5. INTERACTION BETWEEN PAIN SEVERITY AND HARM AVOIDANCE
The	influence	of	pain	severity	on	the	association	between	HA	and	pain-related	
anxiety	resembles	the	finding	concerning	anger	and	depression.	Stronger	pain	is	
associated with a stronger linkage between the variables. When pain is less severe, the 
association is weaker. In other words, the level of the anxiety reaction is dependent 
on the experience of the pain intensity.  Temperament may function as a regulatory 
factor between the external stimulus and its emotional consequence.  Because the 
interaction effect concerned only the HA4 Fatigability subscale instead of total HA, 
again the state effect of pain on HA4 is possible.  However, the HA4 Fatigability scale 
remained	clearly	significant.		In	the	model	of	Cloninger,	HA4	Fatigability	is	related	
to asthenia and loss of energy. Individuals with high HA4 recover from stress more 
slowly (Cloninger et al., 1994). One may assume that individuals with a constantly 
low level of energy are also less able to use effective coping mechanisms, which may 
predispose	to	anxiety.	HA4	may	reflect	a	specific	feature	of	vulnerability	to	pain	or	
chronic pain as a stressor might mold the personality structure.
In conclusion, despite the weaknesses of the cross-sectional study design, our 
results are consistent with those of earlier studies on HA and pain.  Considering the 
lifesaving function of acute pain, fear and avoidance are natural reactions to pain. 
Thus, it is plausible that Harm Avoidance, in molding the individual reactions to 
fear-evoking stimuli, is connected to pain perception, pain behavior, and also to 
the endogenous opioid system.  
6.2.6. ASSESSING DEPRESSION IN CHRONIC PAIN
In chronic pain patients, the validity of the depression assessment instruments 
has been criticized due to the symptom overlap problem as well as limitations 
with self-report. The majority of the psychology-based depression studies in pain 
patients have used instruments such as the BDI, which was designed to measure 
the severity of depression in psychiatric patients. 
Among the chronic pain patients with MDD, the mean BDI score was close to a 
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level corresponding to severe depression (MDD 29.0 vs. no MDD 14.5). Regarding 
the guidelines of the BDI (˂ 9 no depression, 29+ severe depression), the mean 
scores are high.  Comparing the results of the most recent version of the BDI, the 
BDI II (Beck et al. 1996b), with  SCID-based diagnosis of MDD using receiver 
operating characteristic (ROC) analysis,  Poole and colleagues (2009) suggested a 
cut-off score of 22+ as being optimal for screening MDD in chronic pain patients. 
Beck and colleagues (year?) developed a special version of the BDI for medical 
patients (Steer et al., 1999), however, in chronic pain patients this version is seldom 
used in research. 
 Besides Morley, other factor analytic models of depression in pain patients 
exist (Novy et al., 1995, Poole et al., 2006). The factor solutions may vary between 
the models, however, the distinction between somatic and emotional symptoms 
is a characteristic feature.  The usual conclusion has been not to rely on somatic 
items when assessing depression in pain (Morley et al., 2002, Taylor et al., 2005). 
However,	other	factor	analytic	studies	have	presented	conflicting	results,	supporting	
the use of the total BDI score, including the somatic items, as part of the depression 
assessment in chronic pain (Novy et al., 1995, Harris and D’Eon, 2008). Our results 
support the use of the somatic items as part of the depression assessment process.
Only a limited number of publications assessing the relevance of the MDD 
criteria in chronic pain patients are available. In evaluation of 129 chronic pain 
patients, Wilson and colleagues (2001) reported a remarkable decline (from 35.7% 
to 19.4%) in the prevalence of MDD when using alternative DSM criteria or when 
the somatic criteria were excluded if somatic symptoms were attributed entirely 
to pain. However, neither the BDI scores nor the cognitive affective or the somatic 
subscales differed between the groups. The symptoms that were similar between 
depressed and non-depressed pain patients were hypersomnia, appetite gain, weight 
loss or gain, psychomotor retardation, and recent suicidality. The least differing of 
the BDI items were insomnia, weight loss, and somatic preoccupations. 
In the present study, the comparison was made between a categorical method 
and	a	dimensional	method.	The	diagnosis	of	MDD	requires	at	least	five	symptoms	
of nine, several of which are somatic in nature. This may explain the association of 
the physical and somatic function factor with the diagnosis of MDD.  
6.3. STUDY LIMITATIONS AND STRENGTHS
6.3.1. PATIENT SAMPLE
One of the major drawbacks of the study is the highly selected patient sample in a 
tertiary pain clinic, limiting the generalizability of the results.  The patients in the 
clinic represent the most complicated cases of all chronic pain patients.  The majority 
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of the patients have earlier been treated in other clinics with suboptimal treatment 
outcome.   Because psychiatric comorbidity is known to complicate the treatment, 
one may speculate that this comorbidity is prevalent among these patients. In 
addition, patients having more psychosocial stress factors may be more willing to 
participate in the study, causing further bias.  Because of the relatively small sample 
size, the power of the statistical analyses was restricted.  The number of males was 
low (38) relative to females, and the comparisons between genders mostly failed 
to show any differences. Despite chronic pain, the patients in the study formed a 
heterogeneous sample concerning type, location, and duration of pain symptom.
Some of the patients had already been treated in our pain clinic for a time and 
others had started their treatment recently. However, even the latter group of the 
patients had received treatment for chronic pain in other clinics previously.  All 
of the study patients had been prescribed medication for chronic pain. Common 
medications used in pain patients include tricyclic antidepressants and SNRIs, 
affecting pain, anxiety, and depression.  Recent changes in the medication or 
treatment may have occurred prior to the study visit, which may have affected the 
results of the psychological and pain assessment questionnaires. 
6.3.2. STUDY DESIGN
The cross-sectional design of the study is unable to prove any causality.   Assessing 
state effects on trait variables requires a longitudinal study design. In addition, the 
variation	in	pain	intensity	may	influence	the	psychological	symptoms	and	affect	the	
diagnostic process.  Using a single moment for pain severity measurement does 
not yield deeper information concerning the underlying mechanisms between pain 
and psychological symptoms.  Longitudinal studies, on the other hand, are time-
consuming and expensive. Participant drop-out is also a problem.  
The lack of control patients is another limitation.  Determining whether 
depression and anxiety differ between chronic pain patients and psychiatric patients 
requires controls.  However, considering the multiplicity of the confounding factors, 
more than one control group would have been necessary; patients with chronic pain 
without depression or anxiety, patients with depression or anxiety without chronic 
pain, healthy controls, etc.  This would have complicated the structure of the study 
and restricted the research questions.
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6.3.3. SELF-REPORT QUESTIONNAIRES
Data based on self-report questionnaires, such as the STAXI-2, the PASS-20, the 
TCI, and the BDI, may possess reliability and validity problems. A social desirability 
bias is possible, particularly in the case of assessing negative emotions such as anger 
(King and Bruner, 2000). The participants may also understand and interpret the 
questions differently.   Questions regarding the trait-state distinction may require 
thorough reading and understanding of the wording. The ability to assess oneself and 
one`s own emotions also varies between individuals. The self-assessment process 
may also be compromised by several state factors such as the variation in pain 
severity, medication effects, or acute temporary sleeping problems. 
6.3.4. SYMPTOM OVERLAP
Using the SCID interview and DSM to assess mental disorders in chronic pain 
patients has advantages as well as limitations. Compared with the self-report 
questionnaires, SCID and DSM have been regarded as the gold standard.  Using SCID 
and DSM allows a broad spectrum assessment that covers a wide range of symptoms 
as well as comorbidity of the disorders. The symptom overlap problem in chronic 
pain patients is also present with the DSM.  According to the diagnostic guidelines, 
somatic symptoms should be excluded from the diagnosis if they are “clearly and 
fully attributable to the somatic condition” (American Psychiatric Association, 1994). 
However, clear instructions for the assessment are lacking and rely on the subjective 
interpretation of the examiner. In our study, one examiner with formal training in 
use of the SCID performed the clinical interviews. Despite the training and clinical 
experience of the examiner, the subjectivity factor must be taken into account. 
Subjective interpretation is required also in the DSM sections Somatoform disorders 
and Pain Disorder, which were omitted from the diagnostic assessment. This 
decision	was	based	on	the	known	difficulties	concerning	the	reliability	and	validity	
of the diagnoses in pain patients.  Considering the psychological underpinnings of 
chronic	pain,	judgment	of	when	the	psychological	factors	play	a	significant	role	in	
the onset, severity, and maintenance of pain is arbitrary.
6.3.5. RECALL BIAS
The ability of patients to remember the onset of pain and its temporal relationship to 
the emotional symptoms can be questioned. Determination of pain onset was based 
on the pain questionnaire. Onset of psychiatric disorders relied on retrospective 
recall of the time.  Different memory probes were used when determining the 
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time of onset.  However, the validity of both lifetime diagnoses and time onset 
determinations is likely to be lower than that of current diagnoses.
6.3.6. HARM AVOIDANCE
Regarding the personality assessment, only the Harm Avoidance dimension was 
assessed in detail in this study. Cloninger`s model contains a number of other 
factors that might have relevance in chronic pain. Harm Avoidance was chosen 
because it has been the most studied factor in the model. Compared with the 
other dimensions of the TCI, Harm Avoidance has been the most robust and most 
consistently associated with various psychiatric disorders (Miettunen and Raevuori, 
2012).
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7. CLINICAL IMPLICATIONS AND FUTURE    
 PERSPECTIVES
Assessment of symptoms of depression in chronic pain patients is part of the 
general treatment protocol in pain clinics today.  The importance of anxiety in 
pain-related disability has also been recognized.  Among pain studies, the present 
study represents the minority by using psychiatric diagnostic methodology in the 
assessment.  
Recent psychological research paradigms have involved several cognitive models 
linked to pain-related anxiety and depression such as the Fear-Avoidance Model 
of Pain (Lethem et al., 1983, Vlaeyen et al., 1995), the Pain Catastrophizing Model 
(Sullivan et al., 1995), the Pain Acceptance Model (McCracken and Zhao-O’Brien, 
2010), or the Perceived Injustice Model (Sullivan et al., 2012).  One of the main 
differences between the psychological and the psychiatric views has been in a 
dimensional approach versus a diagnostic approach.  The categorical diagnostic 
approach of DSM has been criticized.  Some of the major targets of the criticism have 
involved its descriptiveness of the diagnoses without underlying empiric models, 
the general complexity with a multitude of categories, the heterogeneity within 
a diagnosis, and the comorbidity and overlap between the diagnostic categories 
(Watson et al., 2006).  Another main criticism is the division between cases and 
non-cases.  According to the diagnostic system, one either has a disorder or not. 
Subthreshold non-cases have symptoms, but not enough to justify the diagnosis and 
treatment (Goldberg, 2000). However, the categorical and dimensional views are 
not entirely contradictory, but are partly complementary. The categorical approaches 
include dimensional measurements of severity, and the dimensional approaches 
have severity categories and cut-off scores.  According to Kraemer et al. (2004), every 
disorder is both categorical and dimensional, but in order to reach the best clinical 
or research result one must use a certain approach. One of the major changes in 
the DSM-5 has been the addition of the dimensional assessment in several disorder 
categories.
The psychiatric diagnostic approach is needed to make decisions concerning 
treatment and interventions. The need for the categorical approach is emphasized 
in clinical work and clinical research (Kraemer et al., 2004). Assessment of past 
psychopathology and previous episodes of depression or anxiety provides also 
important background information for the treatment plans.  The psychiatric 
diagnosis may markedly affect the pain treatment procedure by excluding certain 
treatment options or prioritizing others.  Chronic pain patients with a history 
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of bipolar disorder or substance use disorder may have restrictions concerning 
pharmacological treatment options.  Patients with severe major depressive disorder 
may need special support because of their functional impairment and cognitive 
disabilities.  Thus, the psychiatric approach can contribute considerably to the 
multidisciplinary pain management programs.   Together with the psychological 
approach, it can help to develop more individualized and patient-targeted treatment. 
Psychiatric comorbidity is known to complicate the outcome of pain treatment.  One 
explanation may be that the disorders remain poorly diagnosed and untreated or 
the treatment is suboptimal.
The relationship between chronic pain and personality has been less investigated 
in recent years. However, underlying personality structures are known to function 
as predisposing factors for psychiatric disorders. Even if the pain-prone personality 
profile	was	shown	to	be	non-existent,	the	personality	factors	have	relevance	in	pain	
coping and treatment planning. 
Our	findings	highlight	the	difficulties	in	defining	the	borders	between	pain	and	
psychiatric diagnoses. The essential characteristics of depression and anxiety that 
constitute chronic pain remain obscure.  In this study, the somatic items of BDI 
were strongly associated with the diagnosis of MDD, whereas Morley hypothesized 
that depression measured by the BDI is more related to general distress than actual 
depression because of the lack of the negative self-image typical of depression 
(Morley et al., 2002).  The symptom overlap creates a border area where clear 
distinctions	between	pain,	anxiety,	and	depression	are	difficult	or	even	impossible	
to make. The result can be either an over-diagnosis or missed diagnoses. Excluding 
or interpreting strictly the somatic criteria in the diagnostic assessment reduces 
the sensitivity, which may have such serious consequences as increased suicidality 
(Tang and Crane, 2006).   Determining the core or “real” symptoms of depression 
and anxiety in chronic pain becomes a challenge also after considering the common 
neurotransmitter and brain pathway systems. However, due to common background 
mechanisms, some of the effective treatment options are also common, e.g. SNRIs 
or cognitive-behavioral therapy.
Despite the cross-sectional study design preventing causality conclusions in 
our study, some ideas emerge that shed light on underlying mechanisms. As the 
anxiety disorders preceded pain onset, they cannot be a consequence of pain. 
One	explanation	for	the	temporal	finding	is	that	most	anxiety	disorders	develop	
in early adulthood.  This does not, however, explain the high prevalence of anxiety 
disorders in pain patients compared with the normal population.   Some other 
mechanisms, such as common vulnerability factors, could provide explanations 
for the co-occurrence.  Previous studies have suggested an elevated level of Harm 
Avoidance in chronic pain patients relative to controls, however, prospective follow-
up studies are lacking.  In stress-diathesis models in pain, personality has been 
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presented as a possible vulnerability factor for chronic pain and disability (Banks 
and Kerns, 1996).  According to the Fear-Avoidance model of chronic pain, pain 
avoidance	has	been	among	the	main	mechanisms	leading	to	pain	chronification	
and disability (Lethem et al., 1983, Vlaeyen et al., 1995). One may assume that 
individuals with a high level of Harm Avoidance have a tendency to avoid painful 
situations, which may in turn predispose them to disability.
 Harm Avoidance occurs concomitantly with the suppression or inhibition of 
anger.  Anger as a comorbid symptom has evoked little attention in pain research. 
However, anger and aggressive reactions are apt to cause an immense emotional 
burden among personnel in pain management units, while anger inhibition may 
go completely unnoticed.  
 The stigma concerning psychiatric disorders has evoked criticism and concern. 
The pain associated with depression has been described using terms such as 
functional or unexplained, suggesting that the pain is not “real” (Reveler et al., 2006). 
The fear of stigma may have negative consequences. The fear of being labeled as 
having a mental disorder may prevent pain patients from seeking help. In the study 
of Wilson and colleagues (year?), depressed pain patients were inclined to interpret 
the etiology of their symptoms as pain-related instead of connected to depression. 
Concern about stigma has centered around the diagnosis of Pain Disorder in the 
DSM in particular (Young, 2010). The current version, DSM-5, includes major 
revisions of the section Somatoform Disorders. Pain Disorder is incorporated into 
the “Somatic Symptom Disorder” section, with a focus on distress and anxiety 
instead of psychologic etiology or unexplained symptoms (American Psychiatric 
Association, 2013).
	The	definition	of	pain	by	IASP	emphasizes	that	emotions	are	an	essential	part	
of	pain.		Pain	is	a	subjective	experience.		This	close	relationship	has	been	reflected	
in several sections of the current study; the pain experience was associated with 
anxiety and depression despite whether the method of assessment was dimensional 
or	categorical.	Pain	intensity	influenced	the	associations	between	other	emotional	
constructs.		The	findings	of	the	study	are	in	line	with	the	biopsychosocial	model	
of pain. Pain and emotions share similarities and have common underlying 
mechanisms. The boundaries between pain and its emotional components are 
blurred.		One	may	think	that	there	is	a	fuzzy	border	area	that	reflects	the	mind/
body entity where making clear distinctions is not possible. 
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8. CONCLUSIONS
This cross-sectional study showed a high prevalence of psychiatric disorders in 100 
chronic pain patients. The prevalence of anxiety and depression was high compared 
with the general population. The temporal relationship related to pain onset differed 
between the anxiety disorders and the mood disorders. The temperament trait 
Harm Avoidance was associated with pain-related anxiety, and the pain intensity 
influenced	the	strength	of	the	association.	Pain	patients	with	a	tendency	to	inhibit	
their angry feelings had more somatic and physical symptoms of depression 
when the pain experience was stronger relative to those who experienced milder 
pain. Concerning the inhibition of anger and the cognitive-emotional symptoms 
of	depression,	 the	pain	experience	did	not	 influence	 the	association.	 	Both	 the	
cognitive-emotional and somatic-physical symptoms measured by the BDI were 
associated with the diagnosis of depression. However, the diagnosis of MDD was 
more strongly related to the somatic-physical symptoms of the questionnaire.
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